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Riassunto 
 
Questa tesi riguarda la sintesi, caratterizzazione e l’investigazione di una serie di 
composti  nei  quali  il  fullerene  C60,  peptidi  e  radicali  liberi  sono  accoppiati.  In 
particolare, due serie di composti sono stati sintetizzati, caratterizzati dalla presenza 
del fullerene e / o da una funzione nitrossido covalentemente legati alle estremità 
di un piccolo peptide rigido. Le caratteristiche di questo peptide sono tali per cui un 
forte  momento  di  dipolo  molecolare  sorge  orientato  lungo  l’asse  molecolare 
principale. Poiché il verso del dipolo è invertito nelle due serie di composti, chiamati 
2- e 2+, si prevede che l’effetto generato dal dipolo, per esempio sulle proprietà 
redox dei gruppi localizzati alle sue estremità (la funzione nitrossido e il fullerene), 
sia  opposto.  L’analisi  conformazionale  in  soluzione  ha  fornito  utili  informazioni 
riguardo  la  struttura  secondaria  dei  peptidi.  Dalle  misure  elettrochimiche  (cyclic 
voltammetry  e  differential  pulse  voltammetry)  sono  stati  ottenuti  i  potenziali 
standard  dei  composti  sotto  esame.  In  fine,  è  stata  effettuata  la  sintesi  di  due 
fullerene-peptidi impiegando l’endofullerene H2@C60. 
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Abbreviations used 
 
 
                  Symbols and abbreviations for amino acids and peptides are in accord 
with the recommendations of the IUPAC-IUB Commission on Nomenclature (J. Biol. 
Chem. 1972, 247, 977). The optically active α-amino acid is of L-chirality. Other 
abbreviations used are as follow:  
 
Z, benzyloxycarbonyl 
Boc, tert-butyloxycarbonyl  
OtBu, tert-butylester 
Me, methyl 
Aib, α-aminoisobutyric acid 
NMM, N-methylmorpholine 
HOAt, 7-aza-1-hydroxybenzotriazole 
EDC.HCl, N-ethyl-N′(3-dimethylaminopropyl)carbodiimide hydrochloride 
Piv, tert-butyl-carbonyl or pivaloyl 
DIEA, N,N-diisopropyl-ethyl-amine 
DEA, diethylamine 
Fp, fulleropyrrolidine 
Fpr, fulleroproline 
EtOAc, ethyl acetate  
MeOH, methanol 
AcOH, acetic acid  
TEA, triethylamine 
TFA, trifluoroacetic acid  
DCM, dichloromethane 
EtOH, ethanol 
n-BuOH, n-butanol 
TOAC, 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid  
Cyanuric fluoride, 2,4,6-trifluoro-1,3,5-triazine  
py, pyridine 
TMS, tetramethylsilane 
ACN, acetonitrile 
EP, light petroleum 
Fmoc-OSu, N-(9-Fluorenylmethoxycarbonyloxy)succinimide 
Fmoc, N-9-Fluorenylmethoxycarbonyloxy 
Rf, TLC retention factor 
Mp, melting point 
FT-IR, Fourier transformation Infrared spectroscopy 
NMR, nuclear magnetic resonance 
MALDI, matrix-assisted laser desorption ionization 
ESI, electron spray ionization 
CD, circular dichroism 
TR-EPR, time resolved-electronic paramagnetic resonance 
DMF, dimethylformamide   8 
DMSO, dimtheylsulphoxide 
CV, cyclic voltammetry 
DPV, differential pulse voltammetry 
TBAH, tetrabutylammonium hexafluorophosphate 
Fc, ferrocene 
Trt, triphenylmethyl or trityl 
ROESY, rotating-frame Overhauser effect spectroscopy 
SCE, standard calomel electrode 
DCTB, trans-2-[3-(4-tert-Butylphenyl)-2-methyl-2-propenylidene]malonitrile 
DCE, 1,2-dichloroethane 
PH, diphenylhydrazine 
t-, tert- 
r.t., room temperature 
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1. Introduction 
 
1.1 Introduction on Fullerene 
 
                   Buckimsterfullerenes are a family of organic molecules that constitute 
one  of  the  allotrope  forms  of  carbon.  The  name  comes  from  the  architect 
Buckimster Fuller whose constructing philosophy seems inspired by the spherical 
shape built up of fused pentagons and hexagons of fullerenes
1. C60 is the smallest 
stable fullerene containing 20 hexagons  and 12 pentagons
6a, followed then by the 
higher fullerenes such as C70
1. C60 is also known as (C60-Ih)[5,6]fullerene because it 
has 60 carbon atoms that form a sphere belonging to the icosahedral symmetry 
group Ih and the numbers in brackets [5,6] indicate the presence of only pentagons 
and hexagons
1. Since its discovery in the 1985 and its first large scale production in 
the  1990  by  resistive  heating  of  graphite
2,  C60  has  been  subjected  to  several 
investigations  for  its  unique  properties  and  potential  applications  as  a 
superconductor
3,  as  a  ferromagnet
4,  in  electro-optic  devices
5  and  medicinal 
chemistry
6. 
 
 
 
Figure 1.1 The Montreal Biosphere by Buckimster Fuller, Montreal, 1967. 
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1.1.1 Properties of Fullerene C60 
 
                 C60  has  an  outer  diameter  estimated  as  7.10  Å.    If  you  also  take  into 
account the thickness of the π-electron cloud, the diameter becomes 10.34 Å
7.  
                 For the icosahedral symmetry Ih, the state, corresponding to the quantum 
number  5 for the  angular  momentum l,  splits  into the  hu +  t1u  + t2u irreducible 
representations
  8.  The  lowest  occupied  energy  level  HOMO  (highest  occupied 
molecular orbital) , hu, in the neutral C60 is 5-fold degenerated and completely filled 
with 10 electrons
9. The symmetry of orbitals hu is such that antibonding interactions 
with [5,6]-bonds, linking a pentagon with a hexagon, take place whereas bonding 
interactions are promoted for [6,6]-bonds, shared between two hexagons
1,6a,8,10. 
These alternate interactions bring about two different length bonds: the former is 
called “long bond” (1.45 Å long) or 5,6 junction. The latter is the “short bond” (1.38 
Å long) also termed 6,6 junction which possesses more electron density
1,6a,8,10. In 
the lowest energy Kekulè structure, the double bonds are located only at the 6,6 
junction
6a.  
                 C60 strongly absorbs in UV region and weaker but significant bands in the 
visible  region  (410-620nm)  make  C60  solutions  purple,  due  to  orbital  forbidden 
singlet-singlet transitions
1,6a,11,18. Absorptions in the range 190-410 nm are due to 
allowed 
1T1u-
1Ag transitions instead
1,11,18. When functionalized, it retains the same 
basic  characteristics  but,  in  addition,  the  absorption  of  the  derivatives  extends 
further into the near-IR region
12. Its photophysical properties are very interesting. 
When it is photoexcited, the singlet state decays very efficiently via Inter System 
Crossing to the triplet excited state with triplet quantum yields very high (ΦT ≈ 0.96) 
and relative long triplet lifetime (135 μs)
1,12,13,14,15. The triplet state can give off 
phosphorescence
12  or  can  be  deactivated  in  several  ways  such  as  ground  state 
quenching
2, triplet-triplet annihilation
12, electron transfer to acceptor molecules
17, 
quenching  by  molecular  oxygen  leading  to  singlet  oxygen
13,  quenched  by  free 
radicals
16.    
 
 
 
Figure 1.2 Optical absorption spectrum of C60 in hexane. Inset: 420-470 nm region
1.   15 
                  Because of its high symmetry, C60 shows a single peak in the 
13C NMR at 
143.2 ppm
1 in benzene-d6. It was calculated that it has a longitudinal time relaxation 
fairly long, higher than 20 seconds
11.  
                  In electron transfer reactions, C60 plays an important role owe to its low 
reorganization  energy
1,12.  The  buckybull  is  able  to  promote  long-lived  charge 
separated  states
1,17.  Whereas  its  HOMO  is  5-fold  degenerate  and  fully occupied 
with 10 electrons, its LUMO (lowest unoccupied molecular orbital) and LUMO+1 are 
triple degenerated
35 and characterized by a relative low energy
1,19 so that C60 can 
reversibly receive up to 6 electrons in one-electron transfer processes
20. Due to the 
extensive delocalization of the negative charge over many carbon atoms, the mono-
anion is quite stable in the absence of oxygen
14. The voltammetric experiments 
were carried out, for example using the mixed solvent system ACN / toluene 1:5 
and at -10° C. The potentials measured (E1/2) were -0.98, -1.37, -1.87, -2.35, -2.85 
and -3.26 V vs Fc/Fc
+ 19. It is important to emphasize that the penta- and the hexa-
anions are stable and exhibit reversible behavior on the voltammetric time scale
19. 
In the anionic species, Jahn-Teller instability is expected to decrease the symmetry 
of C60
28,30. Lower symmetry is also produced in solvents of low dielectric constant by 
the presence of the counterion
29,30. 
 
Figure 1.3. Reduction of C60 vs Fc/Fc
+ in ACN/toluene 1:5 with TBAH as supporting 
electrolyte at -10° C. A) CV, scan rate = 100 mV s
-1; B) DPV, scan rate = 25 mV s
-1, 
pulse with = 50 mV, period = 300 ms 
19.   
 
Chemical reduction can be carried out employing electropositive metals such as 
alkali  metals
9a,.  These  compounds  show  superconductivity    properties
21.  Some 
organic  donor  molecules  such  as  cobaltocene,  can  form  fully  ionic  salts  with 
fullerene
22.    C60  derivatives  are  characterized  by  a  small  shift  to  more  negative 
values of the reduction potentials in the cyclic voltammograms relative to C60 for 
the first three reduction waves
18,23,24,25.    16 
For  example,  the  potentials  measured  (E1/2)  for  N-methyl-3,4-fulleropyrrolidine 
were -1.05, -1.44, -2.01, -2.42, -3.12 V vs Fc/Fc
+ 24.
 This phenomenon was explained 
considering  that,  the  saturation  of  a  double  bond  generated  by  the 
functionalization, causes a partial loss of conjugation
6a,18. A particular case is offered 
by  derivatives  termed  fulleroids  [5,6]-open  which  are  the  only  derivatives  that 
retains the 60π electron configuration without loss of conjugation, unlike the [6,6]-
closed fullerene derivatives
6a,27 or fulleropyrrolidines. 
 
Figure 1.4 Fulleroid [5,6]open (on the left) and fulleroid [6,6]closed (on the right)
26. 
 
                  In donor-acceptor experiments, where both energy and electron transfer 
processes have been reported, the nature of the spacer was found to play a role
6a. 
For instance,  through bond electron transfer was shown for dyads 1, 2, 3, whereas 
formation of a transient intramolecular exciplex was observed for compounds 4, 5
26 
(Figure 1.5).  
 
Figure 1.5 Dyads examples for electron transfer studies. 
 
While in 1, 2, 3 derivatives, fast charge recombination probably prevents sufficient 
stabilization, the saturated hydrocarbon bridge in dyads 4, 5 is able to avoid charge 
recombination  and  long-lived  charge  separated  states  are  detected  in  polar 
solvents
6a (Figure 1.5).  
                  Oxidation is far less facile than reduction and it occurs at comparatively 
high anodic potentials
19. CV studies showed that the first 1-electron oxidation of C60 
in 1,1,2,2-tetrachloroethane occurs at a very positive potential, +1.26V vs Fc/Fc
+19.   17 
The difference between the first oxidation and the first reduction of C60  at room 
temperature was calculated to be 2.32 V, which is a measure of the HOMO-LUMO 
gap of the molecule in solution
19.  
                  C60 has four IR active stretching: 1430, 1182, 577, 527cm
-1 
11: 
 
Figure 1.6 IR spectrum of C60 in KBr 
1. 
 
                  Interesting investigations can be carried out when the C60 is covalently 
linked  to  a  molecule  bearing  a  free  radical  such  as  TOAC  (2,2,6,6-
tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid). CV at room temperature in 
THF on a Pt electrode, using TBAH as supporting electrolite, show five reversible 
reduction peaks for the fullerene and one irreversible reduction process due to the 
nitroxide substituent, positioned between the second and third fullerene moiety 
reduction steps
30. On the oxidation side, the reversible oxidation of the nitroxide is 
observed
30.  Coupling  between  the  triplet  state  of  fullerene  (generated  after 
photoexcitation) and the doublet state of the nitroxide can be investigated by the 
TR-EPR (time-resolved electron paramagnetic resonance) technique
16,31,32,33.   
                    
1.1.2 About the chemistry of Fullerene C60 
 
                   C60 posses 30 equivalent double 
bonds,  all  sharing  the  same  reactivity 
which  do  not  contain  any  hydrogen  so 
that,  whereas  substitution  reactions  are 
not possible
1, redox and addition reactions 
can lead to several fullerenes derivatives as 
depicted by figure 1.7:  
 
Figure 1.7 a) fullerene salts; b) exohedral 
adducts; c) open cage fullerenes; d) quasi-
fullerenes;  e)  heterofullerenes;  f) 
endohedral fullerenes
1.  
   18 
Since pure p character of  π orbitals is present only when the molecule lies on a 
plane, a rehybridization of the sp
2 σ and the p π orbitals appears to be present in 
the electronic structure of C60 leading to low-lying π
* orbitals with considerable s 
character
35.  As  a  consequence,  C60  shows  an  electrophilic    character  and  it  is 
relatively easy to reduce
1.  All the double bonds are conjugated and enclose in the 
six  member  rings.  Since  they  are  forced  to  deviate  from  planarity
39 
(pyramidalization of the sp
2 carbons), an excess of strain is present quantified to be 
8  Kcal/mol  per  carbon
35.  A  change  towards  the  sp
3-hybridation  promoted  by 
chemical reactions (e.i., addition reactions) is a way for the molecule to release 
strain and in fact, the fullerene greatly favors reactions that decrease strain
35. On 
the  other  hand,  C60  is  very  stable  compared  with  other  fullerenes  since  all  the 
pentagons are isolated by hexagons so that C60 is the smallest fullerene to obey the 
so  called  “isolated  pentagon  rule”
36,37  which  assures  an  enhancement  of  the 
sphericity of the molecule
38. When pentagons are adjacent instead, a resonance 
destabilization  together  with  an  increase  of  strain  energy  is  present  as  a 
consequence of the fact that bonds are forced to deviate from planarity
1. 
                  C60 behaves such as a fairly localized and electron-deficient polyolefin
1,6a. 
In fact, C60 tends to form complexes with electron donors
12. In analogy to olefins, it 
undergoes cycloadditions
50. In particular, [3+2] cycloaddition with 1,3 dipole such as 
azomethine  ylide  was  the  synthetic  route  employed  in  this  work  to  obtain  N-
substituted-3,4-fulleropyrrolidines,  where  the  3,4-bond  of  a  pyrrolidine  ring  is 
covalently attached to a 6,6 ring junction of the fullerene moiety. The reaction is 
regioselective because only the [6,6] bond is attached. Indeed, the [6,6] double 
bonds  of  C60  exhibit a dienophilic  character
40. Besides,  azomethine  ylide  can  be 
easily generated in situ from several readily accessible materials. 
                    In  this  work,  the  1,3  dipole  was  obtained  by  decarboxylating  the 
condensation  product  of  N-substituted  glycines  with  formaldehyde  (see 
experimental part)
41.   
                    The answer to the question “is C60 aromatic?”
64 is still debated because 
there is no suitable model to serve as a reference compound
64. Several criteria were 
been  taken  into  account.  C60  is  not  planar  and  does  not  undergo  substitution 
reactions typical of planar aromatics. On the other hand, from an energetic point of 
view, it shows an aromatic stability. Calculation of nucleus-independent chemical 
shift has revealed diatropic hexagons (aromatic molecules sustain diamagnetic ring 
current) and paratropic pentagons characteristic of antiaromatic molecules so that 
C60  can  be  defined  “ambiguously  aromatic”
35.  These  two  contributions  cancel 
almost exactly and there is virtually no ring-current contribution to the magnetic 
susceptibility.  To  quote  Haddon
35,  “C60  molecule  posses  anomalous  magnetic 
properties but with the reactivity of a continuous aromatic molecule, moderated 
only by the tremendous strain inherent in the spheroidal structure”.  
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1.1.3     The endofullerene H2@C60 
 
                   Since fullerenes are hollow molecules it should be possible to trap atoms 
inside the  cage. Such particular fullerenes are called endofullerenes. The symbol @ 
is used to indicate the atoms in the interior of the fullerene. All atoms listed to the 
left  of  the  @  symbol  are  located  inside  the  cage.  In  this  thesis  work,  H2@C60 
endofullerene with encapsulated hydrogen was used. The synthetic approach for 
obtaining  H2@C60  was  termed  “molecular  surgery  strategy”
43  that  employs  the 
following  steps
44:  (1)  creating  a  hole  on  the  C60  surface  by  a  cage  opening;  (2) 
increasing the size of the hole until its size allows insertion of H2; (3) insertion of H2 
at 800 atmospheres and at 200°C in a autoclave for 8 hours; (4) closing the hole to 
regenerate the C60 fullerene host with an incarcerated H2 guest. Upon return to 
room  temperature  and  atmospheric  pressure,  the  H2  is  incarcerated  and  stable 
inside the fullerene
42. 
 
Figure 1.8. Synthetic scheme for the synthesis of H2@C60 
43. 
 
                  Incarceration of H2 inside C60 inﬂuences the NMR properties of H2. For 
example,  the  chemical  shift  of  H2  in  organic  solvents  is  typically  found  at 
approximately +4.5 ppm, whereas the chemical shift of H2@C60 is found at much 
higher  ﬁelds,  approximately  -1.3  ppm,  “to  the  right  of  TMS” 
45.  The  very  small 
downfield  shift  (0.078  ppm)  observed  for  the 
13C  NMR  signal  of  H2@C60  (as 
compared to empty C60) indicates that the electronic  property  of  the  fullerene  
cage  is largely unaffected by the encapsulation of H2
43. 
                   
1.2 Nitroxide radicals in solution
49 
 
                    Nitroxide  free  radicals,  such  as  the  aminoacid  TOAC,  have  found 
applications in many fields and in particular, they are commonly used in the study of 
conformation  and  structural  mobility  of  peptides  and  proteins
110  by  EPR 
spectroscopy where they are employed as spin probes and spin traps. The ground  
state of a nitroxide mono radical is a doublet (s = ½). EPR spectrum of nitroxide   20 
radicals  at  r.t.  and  in  solution  at  low  viscosity  (fast  orientational  averaging)  are 
characterized  by  three  hyperfine  lines  (Figure  1.9)  due  to  the  coupling  of  the 
unpaired electron on the p
π
z  of the nitrogen atom with the nuclear spin I = 1 of the 
nitrogen  atom  itself  (
14N).  Under  the  application  of  a  magnetic  field  B,  the 
degeneracy of the electron spin states ms = ±1/2 is lifted and transitions between 
the spin levels are induced by radiation of the appropriate frequency. The Spin 
Hamiltonian, also known as Zeeman Hamiltonian, is the following: 
 
Ĥs = gμBBŜZ 
 
where g is called g-value (ge = 2.00232 for a free electron), μB  is the Bohr magneton 
(9.274  x  10
-28  J  G
-1),  B  is  the  magnetic  field  strength  in  Gauss  and  ŜZ    is  the  z-
component of the spin angular momentum operator (the magnetic field defines the 
z-direction). The difference in energy between the two spin energy levels is: 
 
∆E = gμB B = hν 
 
corresponding to the energy, hv, of a photon required to cause a transition. The 
unpaired electron interacts with its environment and the details of EPR spectra 
depend on the nature of those interactions. Because the nitrogen magnetic nuclei 
interact with the unpaired electron, we have another perturbation of the electron 
energy which enters in the Spin Hamiltonian with the term î
.A
.Ŝ where A is the 
hyperfine  coupling  parameter.  In  solution  at  low  viscosity,  due  to  the  rapid 
molecular tumbling, all the anisotropic interactions are averaged on time. Purely 
isotropic coupling aN is responsible for the appearance of multiplets constituted of 
(2I+1) 3 lines. The Fermi contact interaction, for example, leads to pure isotropic 
interaction and is due to the non-zero probability to ﬁnd  the electron spin at the 
same  point  in  space  as  the nuclear  spin.  This happens  only  when  the  unpaired 
electron is in an s orbital because this orbital does not have any nodal plane at the 
nuclei.  
                  The parameters g and the hyperfine splitting factor a are characteristic for 
every paramagnetic species. In case of nitroxides, g value of 2.0061 and aN ~ 15.3 G 
14,30-34  are found. The energy of the transition corresponding to central line in the 
nitroxide continuos wave EPR spectrum is gISOμBB = hν. Since μB and h are constant, 
ν is known (the frequency is fixed and it depends on the instrument) and B can be 
read from the spectrum, it is thus possible to obtain the gISO  value of the specie 
under investigation. In the fast orientational averaging, g value is to be regarded as 
an effective value averaged over all orientations gISO = (gx + gy +gz) / 3. Furthermore, 
the three line in the spectrum EPR are equally spaced of 
 
ΔB = aN (g/ge) 
 
Therefore it is possible to obtain the hyperfine parameter aN once that the g value 
is calculated. 
                   In  this  work,  an  X-band  (ν  =  9.5  GHz)  cw  EPR  (continuous  wave) 
instrument was employed. For technical reasons, best sensitivity and resolution in 
EPR is achieved at fixed microwave frequency. The magnetic field is swept and at   21 
the same time modulated with a frequency of 100 KHz. The field modulation causes 
a signal modulation at the same frequency of 100 KHz. Phase-sensitive detection of 
this modulation yields the derivative of the absorption spectrum. 
Figure  1.9  Schematic  energy  level  scheme  and  cw  EPR  spectrum  of  a  nitroxide 
radical in the regime of fast orientational averaging. Only the electron Zeeman and 
14N hyperﬁne interactions are here considered. 
 
1.2.1 About TOAC amino acid 
 
                    TOAC  is  an  uncoded  aminoacid  characterized  by  a  piperidinic  ring 
bearing a free radical (the nitroxide group) stabilized by the steric hindrance due to 
the  two  next  tetrasubstituted  carbons  that  prevents  dimerization  and  by 
delocalization over the N-O bond
51.  
                    Its  synthesis  starts  from  2,2,6,6-tetramethyilpiperidin-4-one  which  is 
converted  to  2,2,6,6-tetramethetylpiperidin-1-oxyl-4-one  (4-oxo-TEMPO)  through 
oxidation with H2O2  in presence of Na2WO4 (sodium tungstate).  
 
Figure 1.9 Synthesis scheme of TOAC aminoacid. 
 
The  last  step  includes  the  transformation  of  the  ketone  intermediate  into  the 
spyrohydantoine which is hydrolyzed to aminoacid using Ba(OH)2 in water at 135°C 
for 48 hours
52.    22 
                  TOAC is characterized by a weak absorption band (ε = 5-20 L cm
-1 mol
-1) in 
the visible spectral region (λ = 420-450 nm) assigned to the n → π* transition of the 
nitroxide chromophore
53. 
                  TOAC  derivatives  can  not  be  characterized  by 
1H  NMR  because  the 
paramagnetic center relaxes very fast thus causing strong broadening of NMR lines 
of nuclei in its vicinity. Even at distances longer than 6 Å, NMR lines may still be 
broadened beyond detectability
49. 
 
1.3  α-aminoisobutyric acid (Aib) and the 310-helix 
 
                TOAC is  tetrasubstituted at the α carbon and likewise Aib, which is another 
example of C
α-tetrasubstituted α-aminoacid, is remarkably rigid and subjected to an 
elevate restriction to its accessible conformational spaces. As a consequence, it is 
very  efficient  to  induce  β-turn  or  310  /  α-helical  structures  in  peptides
54.  In 
particular, very short Aib-homo-peptides (until 6 residues) show a high tendency to 
assume the 310-helical structures
55,56.  
Figure 1.10 Molecular structures of Aib (on the left) and TOAC (on the right). 
 
It was demonstrated not only that the tendency of Aib-homopeptides to form β-turns 
and 310-helices starts already from the tripeptide
56-61 but also that TOAC follows the 
same structural tendencies of Aib
62,63. The 310-helix and the α-helix are the most 
commune helices
56 which are substantially different as pointed out in the following 
chart
56: 
 
  310-helix 
 
α-helix 
Ψ  -30°  -42° 
Φ  -57°  -63° 
Rotation per residue  111°  99° 
Number of residues per turn  3.24  3.63 
Pitch  6.29 Å  5.67 Å 
 
The parameters above show how the 310-helix is more elongated and narrower than 
the α-helix.  
O
O- +H3N
N
O
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Figure 1.11 Section of 310-helix  (on the left) and section of α-helix  (on the right). 
 
Besides, the 310-helix is stabilized by intramolecular H-bond between the C=O group 
of the residue in the i-position and the N-H group of the residue in position i+3.  For 
the α-helix, it is the N-H group of the residue in position i+4 involved in the H-bond, 
instead.  
   
 
Figure 1.12 The intramolecular H-bond of an Aib-peptide are depicted with a dotted 
line. 
 
                   It is worthwhile to note that Aib homopeptides posses an high tendency 
to  give  raise  to  structured  peptides  which  is  already  evident  from  very  short 
oligomers
62,64,65. A framework of intramolecular C=O···H-N hydrogen bonds cause 
C=O and N-H groups to align significantly along the peptide axis. Consequently, 310-
helices are characterized by a strong oriented dipole moment developing along the 
peptide backbone
62,64,-68. The unique rigidity of short Aib homopeptides together 
with  the  excellent electronic  communication provided by  the peculiar backbone 
stiffness qualify them as a successfully spacers or templates in electrochemical and 
spectroscopic investigations
69. Molecular spacers are linear structure which enable 
to locate probes at known distances and positions in the space. The Maran group 
has  previously  studied  ET  reactions  across  Aib  homo-oligopeptides  using  donor-
peptide-acceptor systems in solution
66,67. Evidence was obtained for a mild distance 
dependence of the ET rate and even an increase of the rate at a certain peptide 
length. This outcome was rationalized by considering that while addition of a new 
α-amino acid unit increases the donor-acceptor distance, it also introduces new 
intramolecular  hydrogen  bonds  that  act  as  efficient  ET  shortcuts,  thereby 
counteracting the usually observed exponential drop of the ET rate with distance. 
Theoretical studies supported the general features of this experimental finding
70,71. 
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1.4 Characteristics of the investigated fullerene-peptides 2+ 
and 2- 
 
                  Two  couples  of  fullerene-peptides  were  synthesized,  differing  in  the 
direction of the dipole moment: a couple termed plus with the positive pole of the 
dipole moment oriented toward C60 and a minus couple where the dipole moment 
is reversed. The name of the  fullerene-peptide is given as composed by a number, 
which refers to the number of intramolecular hydrogen bonds, and a plus or minus 
sign,  which  refers  to  the  orientation  of  the  dipole  moment.  Each  couple  is 
composed by the fullerene-peptide and its reference, that is, the fullerene-peptide-
reference where the TOAC residue is substituted by an Aib residue. 
 
 
Figure 1.13 a) secondary structure of fullerene-peptide 2+; b) primary structure of 
fullerene-peptide 2+.  
 
                       Figure  1.15  shows  the  primary  and  secondary  structure  of  the 
fullerene-peptides 2+.  In the fullerene-peptide 2+ reference, TOAC is substituted by 
Aib.  The  fullerene-peptide  2+  is  used  in  the  following  discussion  to  explain  the 
general  design  of  our  systems.  The  head  of  our  system  is  represented  by  the 
fulleropyrrolidine that allows to grasp the fullerene to the peptide via amide bond. 
On the other terminus, where TOAC is positioned, there is a tert-butyl amide group.  
 
a) 
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Fulleropyrrolidine and TOAC, the only redox active groups in the experimentally 
applied potential window, are spaced by a small peptide. Figures 1.15 a, b help to 
understand better the orientation of the dipole. The helicity of the system infers a 
particular orientation to the aminoacidics residues, orienting all C=O groups toward 
the C terminus and all N-H groups toward C60. Accordingly, the dipole moment has 
the plus pole by the fullerene moiety.  
                     A minus fullerene-peptide was synthesized to investigate the effect of 
reversing the dipole moment and to compare the results with the plus fullerene-
peptide. In the minus fullerene-peptide the characteristics of the design are the 
same,  but  while  fulleropirrolidine  is  now  attached  to  the  C  terminus  that  now 
becomes the head of the fullerene-peptide, the t-butyl amide group is on the other 
terminus  that  becomes  the  tail  where  TOAC  is  located.  Figure  1.16  shows  the 
primary (a) and secondary structure (b) of the fullerene-peptide 2-. In the fullerene-
peptide 2- reference, TOAC is substituted by Aib. From the 3D structure we can 
notice that the C=O groups are now oriented toward C60, while the NH groups are 
oriented toward the tail of the peptide represented by TOAC. Consequently, the 
negative pole of the dipole moment is by the fullerene. 
 
 
Figure 1.14 a) secondary structure of fullerene-peptide 2-; b) primary structure of 
fullerene-peptide 2-.  
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                     To  gain  a  full  understanding  of  investigated  compounds,  two  other 
peptides-reference  2+  and  2-  were  synthesized  which  lack  only  of the  fullerene 
moiety. These two peptides-reference retain the same number of intramolecular 
hydrogen bonds of the fullerene-peptides 2+ and 2- and differ from each other only 
from the position of the TOAC residue which is located on the N-terminus on the 
peptide-reference  2-  and  on  the  C-terminus  on  the  peptide-reference  2+.  A 
complete overview of compounds-set is shown in figure 1.15. 
 
 
 
 
 
Figure 1.15. Primary structures of compounds-set. 2- series (from the top): fullerene-
peptide 2-, fullerene-peptide-reference 2-, peptide-reference 2-. 2+ series (from the 
top): fullerene-peptide 2+, fullerene-peptide-reference  2+, peptide-reference 2+. 
 
                       In addition, we were provided with some sample of H2@C60 to carry 
out the synthesis of H2@fullerene-peptides 2+ and 2-.  
Figure 1.16 Molecular structures of the endofullerene-peptide 2- (on the left) and 2+ 
(on the right). The two balls inside the C60 cage stand for the hydrogen molecule. 
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1.5 Purpose of the thesis 
 
                 Aim of this Thesis  is  the  synthesis, characterization and investigation of a 
series  of  compounds  in  which  fullerenes,  peptides,  and  radicals  are  coupled.  In 
particular,  two  series  of  compounds  (shown  in  the  previous  paragraph)  were 
synthesized which are characterized by the presence of a fullerene moiety and / or 
of  a  nitroxide  function  covalently  linked  at  the  extremity  of  rigid  peptide.  The 
features of the peptide are such that a strong oriented dipole moment, oriented 
along  the  main  molecular  axes,  arises.  The  direction  of  this  peptide  dipole  is 
reversed in the two series named 2+ and 2-. The investigation of this two series of 
compounds could, in principle, elucidate how this electric macrodipole affects the 
moieties (fullerene and the nitroxide function) located at its extremity. 
                 It is worthwhile to note that Aib homopeptides posses an high tendency to 
give  raise  to  structured  peptides  which  is  already  evident  from  very  short 
oligomers
62,64,65. The unique rigidity of short Aib homopeptides, provided by the 
peculiar backbone stiffness, qualify them as a successfully spacers in spectroscopic 
investigations. Thank to this unique feature, it can be assumed that the nitroxide-
C60 distance in the fullerene-peptides, obtained from molecular modeling, is a good 
approximation to the true value. An accurate estimation of the distance is crucial 
for  several  investigations  where  the  interactions  between  the  fullerene  (or  the 
hydrogen molecule encapsulated inside its cage) and the nitroxide are distance-
dependent.              
                The  synthesis  of  most  of  the  systems  and  the  electrochemical 
measurements were performed at the University of Padova. Part of the synthesis 
and some characterization work, in particular 
1H NMR experiments, were carried 
out in the research group of Professor Nicholas J. Turro (Department of Chemistry 
and Biochemistry of Columbia University, New York). It is worth to say that 
1H NMR 
spectra of nitroxide derivatives are fairly rare in literature since they are more often 
identified by mass analysis and elemental analysis.  
               At  the  Columbia  University  I  also  had  an  outstanding  occasion:  I  was 
provided  with  a  small  amount  of  H2@C60  and  this  allowed  us  to  carry  out  the 
synthesis of the fullerene-peptides 2+ and 2- employing this precious endofullerene. 
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2. Experimental 
 
2.1  Chemicals 
 
        Unless stated otherwise, all chemicals commercially available were used as 
received. Fullerene-C60 (99.5%), benzyl bromoacetate (96%), Boc-L-Ala-OH (99%), 
cyanuric  fluoride  (97%),  Z-Ala-OH  (99%),  sarcosine tert-butyl  ester  hydrochloride 
(97%), trifluoromethansulfonic acid (99%), 2-bromoisobutyryl bromide (98%), silver 
trifluoromethanesulfonate  (≥99%),  silver(I)  oxide  (99.99%),  paraformaldehyde 
(95%),  formaldehyde  (water  solution  37%),  N-triphenylmethyl-glycine  (98%), 
triphenylmethylamine (99%), 2-aminoisobutyric acid (99%), Fmoc-OSu (98%), Fmoc-
Aib-OH  (99%),  N,N-diisopropylethylamine  DIEA  (99%),  Na2S2O4  sodium  dithionite 
(85%),  1,2-dichloroethane  (HPLC  grade,  ≥99.8%)  were  purchased  from  Sigma-
Aldrich.  L-Alanine  tert-butyl  ester  hydrochloride  (99%),  ethanol  (HPLC  grade, 
≥99.8%), Palladium on activated charcoal (10% Pd)  were purchased from Fluka. 
EDC
.HCl,  HOAt  were  purchased  from  GL  Biochem.  CHCl3  (HPLC  grade,  ≥99.8%), 
MeOH (HPLC grade, ≥99.8%), toluene (HPLC grade, ≥99.8%)  were purchased from 
HiPerSolv  Chromanorm.  1,4-dioxane  (99.8%)  was  purchased  from  Lab-Scan 
Analytical  Sciences.  DCM  (HPLC  grade,  ≥99.5%)  was  purchased  from  Carlo  Erba 
Reagents.  ACN  (HPLC  grade,  ≥99.9%)  was  purchased  from  LiChroSolv.  3-trityl-5-
oxazolidinone
73,  3,4-fulleropyrrolidine
24,41, Boc-Ala-Fp
75, Fmoc-TOAC-OH
76, Z-(Aib)2-
OMe
81,  Z-(Aib)3-OH
81  were  synthesized  as  previously  reported.  The  synthesis  of 
compounds  with  the  endofullerene  was  performed  according  to  the  procedure 
followed for the synthesis of analogous compounds  with the empty fullerene. The 
1H  NMR  signal  of  the  encapsulated  hydrogen  falls,  in  all  these  endofullerene 
derivatives, at -4.47 ppm to the right of TMS. 
 
2.2  Instrumentations 
 
               Separations by flash chromatography were performed using silica gel 60M 
(0.04 - 0.063 mm, Macherey-Nagel) as stationary phase. Macherey-Nagel TLC-cards 
(0.2 mm silica gel supported on plastic sheets)  were used for TLC analysis and spots 
were visualized under UV light (λ = 254 nm) and after exposition to iodine vapor and 
KMnO4  water  solution.  Reaction  residues,  dissolved  in  the  minimal  amount  of 
solvent,  were  directly  loaded  into  the  column. 
1H  and 
13C  NMR  spectra  were 
recorded  on  Bruker  AC200  spectrometer  operating  at  200  MHz  and  50  MHz 
respectively and using a Bruker Ascend operating at 500 MHz. Two-dimensional  
spectra were obtained from ROESY experiments carried out in deuterochloroform. 
Chemical  shifts  are  given  in  parts  per  million  (δ)  relative  to  TMS. 
1H-NMR  of 
compounds containing TOAC residue were obtained by mixing 1 mg of compound in 
500 μl of ACN-d3/D2O 1:1 with 2 equivalents of Na2S2O4
  72. Splitting patterns are 
abbreviated as follows: (s) singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet.  
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FT-IR (Fourier transformed Infrared) spectra were recorded on a Perkin-Elmer 1720 
X spectrophotometer using either KBr drifts or 1mM – 0.1mM CHCl3 solutions on 
cells of 1 mm / 10 mm path length. ESI-mass spectra (electron spray ionization) 
were obtained with a Mariner mass spectra, model ESI-TOF, Perspective Biosystem. 
MALDI-TOF mass spectra (matrix-assisted laser desorption ionization, time of flight) 
mass spectrometry  experiments were carried out using an Applied Biosystems 4800 
MALDI-TOF / TOF spectrometer equipped with a Nd:YAG laser operating at 355 nm. 
The laser firing rate was 200 Hz and the accelerating voltage was 25 kV. DCTB, trans-
2-[3-(4-tert-Butylphenyl)-2-methyl-2-propenylidene]malonitrile  was  employed  as 
matrix.  Mp  (Melting  point)  were  measured  by  means  of  a  Leitz  device,  model 
Laborlux  12,  equipped  with  a  warming  table.  Mp  are  not  corrected.  UV-vis 
absorbtion  spectra  were  taken  in  CHCl3  with  a  Agilent  spectrophotometer.  The 
systems concentrations were chosen to provide an optical absorbance A near 350 
nm of ~ 1.0. The experiments were carried out at room temperature. Steady-state 
EPR spectra were acquired using a continuous wave Bruker ER 041 XG  X-band (ν = 
9.75243 GHz) spectrometer. 
 
2.2.1 Electrochemistry 
 
                The electrochemical experiments were performed by using an homemade 
glassy carbon, GC, electrode that was prepared by sharpening a 3 mm diameter 
Tokai GC-20 rod to obtain a disk with a radius of 0.56 mm.  The GC was connected 
to a copper wire with silver epoxy and then sealed in glass tubing with epoxy (Torr 
Seal). The electrode was polished using silicon carbide papers (500, 1000, 2400, and 
4000), diamond pastes (Struers: 3, 1, and 0.25 mm), alumina (BDH: 0.075 and 0.015 
mm), and then stored in ethanol. Before experiments, the electrodes were polished 
with 0.015 mm alumina, ultrasonically rinsed with ethanol for 5 minutes, washed 
with  acetone,  and  carefully  dried  with  a  cold  air  stream.  The  electrodes  were 
electrochemically  activated  in  the  background  solution  by  means  of  several 
voltammetric cycles at 0.5 V s-1 between the anodic and cathodic potential limits of 
concern.  The  electrode  areas  were  determined  by  measuring  the  voltammetric 
current  for  the  oxidation  of  ferrocene  in  DMF/0.1  M  tetra-n-butylammonium 
perchlorate, in which ferrocene has a diffusion coefficient of 1.13 ´ 10-5 cm
2 s
-1. 
Ferrocene Fc (Carlo Erba) was recrystallized by sublimation using a cold finger. A CHI 
660c electrochemical workstation was used for both differential pulse voltammetry 
(DPV) and cyclic voltammetry (CV) experiments. The solvent was 1,2-dichloroethane 
(DCE, Sigma Aldrich, HPLC grade 99.8%) containing 0.1 M tetra-n-butylammonium 
hexafluorophosphate (TBAH) as the supporting electrolyte. TBAH (Fluka, 99%) was 
recrystallized from ethanol. For DPV, we used peak amplitude of 50 mV, pulse width 
of  0.05  s,  2  mV  increment  per  cycle,  and  pulse  period  of  0.1  s.  For  the  CV 
experiments, we employed the feedback correction to minimize the ohmic drop 
between the working and the reference electrodes. All electrochemical experiments 
were  conducted  under  an  Argon  atmosphere  in  an  all-glass  microcell  that  was 
thermostated at 25 °C. A Pt wire was the counter electrode and an Ag wire was 
used as a quasi-reference electrode. 
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 The  Ag  wire  was  kept  in  a  tube  filled  with  the  same  electrolyte  solution  but 
separated  from  the  main  working  vessel  by  a  Vycor  frit.  The  behavior  of  the 
electrode and the quality of the solvent/electrolyte system was first checked in the 
background solution by using CV. At the end of each experiment, the reference 
electrode  potential  was  calibrated  against  the  ferricenium/ferrocene  (Fc
+/Fc) 
couple. 
 
2.3  Synthesis of fullerene-peptide 2- 
 
(Boc-Ala)2O 
 
84  mg  (0.44  mmol,  2  equiv)  of  Boc-Ala-OH  were  dissolved  in  10  mL  of 
anhydrous ACN cooled to 0°C before adding 40 mg of EDC
.HCl (0.21 mmol, 1 equiv). 
The solution was stirred for 30 minutes at 0°C and 4 h at r.t.. Disappearance of Boc-
Ala-OH  was  monitored  by  TLC  (eluent  EP/EtOAc  1/1).  Afterwards,  solvent  was 
removed under reduced pressure and product was immediately used for coupling 
with fulleropyrrolidine. 
 
EDC.HCl
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OH
H
N
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O H
N
Boc Boc Boc
 
 
Fmoc-TOAC-(Aib)2-OMe 
 
450  mg  (1.34  mmol,  1  equiv)  di  Z-(Aib)2-OMe  was  dissolved  in  20  ml  of 
MeOH and 50 mg of Pd/C 10% (10% w/w) were added. After stirring for 1 h under 
hydrogen bubbling, the mixture was centrifuged in order to remove the catalyst and 
solvent was evaporated under reduced pressure and then under vacuum. 0.7 g di 
Fmoc-TOAC-OH (1.61 mmol, 1.2 equiv) were suspended in 5 ml of  anhydrous DCM 
and 263 mg (1.93mmol, 1.44 equiv) of HOAt and 370 mg (1.44 mmol, 1.2 equiv) of 
EDC.HCl  were  added.  The  mixture  was  stirred  for  1  h  at  0°C  until  complete 
dissolution of reagents and then poured into the flask containing H-(Aib)2-OMe and 
233  μl  (1.34  mmol,  1  equiv)  of  DIEA.  After  stirring  for  3  days,  solvent  was 
evaporated under reduced pressure and the residue was washed with 2x50 ml of a 
10% KHSO4 water solution, 30 ml of water, 2x50 ml of a 5% NaHCO3 water solution, 
50 ml of water and finally dried over Na2SO4. Solvent was evaporated and product 
was crystallized from EP/EtOAc affording 567 mg (yield 68%) of a yellowish solid. 
TLC: Fmoc-TOAC-(Aib)2-OMe, eluent CHCl3/EtOH 9/1, Rf 0.7. 
 
Mp: 190-192°C 
FT-IR (KBr) (cm
-1) 3361, 2986, 2941, 1705, 1522, 1455, 1383, 1251, 1150, 1106, 
1028, 909, 737, 642.  
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) 7.85 (m, 2H), 7.63 (m, 2H), 7.39 (m, 
4H), 4.47 (m, 2H), 4.26 (m, 1H), 3.57 (s, 3H), 1.35 (m, 24H). 
ESI-MS C34H45N4O7 (MW = 621) m/z =  622 [M+H]
+      
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Piv-TOAC-(Aib)2-OMe 
 
400 mg (0.64 mmol, 1 equiv) of Fmoc-TOAC-(Aib)2-OMe were dissolved in 8 
ml of ACN and 2 ml of Et2NH  were added. After stirring for 1.5 h, solvent was 
evaporated  and  the  residue  was  purified  through  flash  chromatography  using 
DCM/MeOH 9/1 as eluent. Solvent was removed under reduced pressure and under 
vacuum  affording  253  mg  of  H-TOAC-(Aib)2-OMe  (0.63  mmol,  98%  yield). 
Subsequently, the deprotected peptide was dissolved in 20 ml of anhydrous DCM 
together with 220 μl (1.26 mmol, 2 equiv) of DIEA. 156 μl (1.26 mmol, 2 equiv) of 
Piv-Cl in 3 ml of anhydrous DCM were added dropwise and the solution was stirred 
for  1  day.  Solvent  was  removed  under  reduced  pressure  and  the  residue  was 
washed with 3x50 ml of a 10% KHSO4 water solution, 50 ml of water, 3x50 ml of a 
5% NaHCO3 water solution, 50 ml of water and finally dried over Na2SO4. Solvent 
was evaporated and product was crystallized from EP/EtOAc affording 230 mg (yield 
74%). TLC: Fmoc-TOAC-(Aib)2-OMe, eluent CHCl3/EtOH 9/1, Rf 0.5. 
 
Mp: 253-255°C 
FT-IR (KBr) (cm
-1) 3398, 3328, 2978, 1729, 1688, 1644, 1529, 1452, 1363, 1302, 
1225, 1157, 994, 883, 628.   
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) δ 7.28 (s, 1H), 7.06(d, 2H), 3.58 (s, 3H), 
2.34 and 2.37 (two s, 2H), 2.15 and 2.07 (two s, 2H), 1.51 (s, 6H), 1.38 and 1.32 (s, 
18H), 1.18 (s, 9H). 
ESI-MS C24H43N4O6 (MW = 483) m/z = 484 [M+H]
+       
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Piv-TOAC-(Aib)2-OH 
 
170 mg (0.27 mmol, 1 equiv) of Piv-TOAC-(Aib)2-OMe were suspended in 2 
ml of MeOH and 322 mg (8.04 mmol, 30 equiv) of NaOH in 2 ml of water were 
added. After stirring for two days, the solution was diluted with EtOAc up to 100 ml 
and washed with a 3x100 ml of a 10% KHSO4 water solution, 100 ml of water and 
finally solvent was evaporated under reduced pressure and under vacuum. 82 mg 
(yield 63%) of a yellowish solid were obtained after crystallization from EtOAc/EP. 
TLC: Piv-TOAC-(Aib)2-OH, eluent CHCl3/EtOH 9/1, Rf 0.1. 
 
Mp: 242-244°C 
FT-IR (KBr) (cm
-1) 3308, 2978, 1742, 1644, 1526, 1458, 1383, 1363, 1312, 1221, 
1170, 1113, 883, 676, 639, 608.   33 
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) δ 7.35 (s, 1H), 7.07 (s, 1H), 7.04 (s, 
1H), 2.35 and 2.27 (two s, 2H), 2.14 and 2.07 (two s, 2H), 1.51 (s, 6H), 1.39 (m, 12H), 
1.32 (s, 6H), 1.17 (s, 9H).  
ESI-MS C23H41N4O6 (MW = 469) m/z = 470 [M+H]
+      
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Piv-TOAC-(Aib)2-Ala-Fp 
 
50 mg (0.05 mmol, 1.1 equiv) of Boc-Ala-Fp were dissolved in 15 ml of CHCl3 
together with 15 ml of TFA. After stirring for 1 h at r.t., solvent was evaporated and 
the residue washed with 4x30 ml of Et2O. 23 mg (0.05 mmol, 1 equiv) of Piv-TOAC-
(Aib)2-OH were dissolved in 5 ml of anhydrous CHCl3 and 11 mg (0.06mmol, 1.2 
equiv) of EDC
.HCl were added. After stirring at r.t. for 1 h, the solution was cooled 
down to 0°C and poured in the flask containing H-Ala-Fp and 16 μl (0.14 mmol, 3 
equiv) of DIEA in 50 ml of anhydrous CHCl3. The mixture was stirred at r.t. for 7 
days. Solvent was removed under reduced pressure and the residue was washed 
with 2 ml of MeOH and then 2 ml of toluene in a centrifuge tube. Subsequently the 
residue was subjected to flash chromatography, eluent CHCl3, CHCl3/EtOH 200/1, 
100/1, 50/1 to afford 11 mg of a brown solid (yield 18%). TLC: Piv-TOAC-(Aib)2-Ala-
Fp, eluent CHCl3/EtOH 9/1, Rf  0.4; eluent toluene/EtOH 8/1, Rf 0.2. 
 
IR (1mM, CHCl3) (cm
-1) 3466, 3436, 3344, 1661, 1513, 1494, 1456, 1380, 1363. 
1H NMR (500 MHz, CDCl3, 10 equivalents PH) 7.72 (d, 1H), 6.70 (s, 1H), 6.40 (s, 1H), 
5.75-5.50 (m, 3H), 5.26 (m, 2H), 2.38-2.34 (m, 2H), 2.24-2.21 (m, 2H), 1.68-1.51 (m, 
21H), 1.39-1.31 (m, 15H).  
MALDI-MS C88H49N6O6 (MW=1285) m/z= 1308 [M+Na]
+ 
UV-vis (CHCl3) λ (ε) 310 (24800), 430 (2700) 
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2.4 Synthesis of fullerene-peptide 2+ 
 
H-TOAC-NHtBu 
 
To a suspension of 0.5 g (1.15 mmol, 1 equiv) of Fmoc-TOAC-OH in 30 ml of 
anhydrous DCM, were added 190 mg (1.38 mmol, 1.2 equiv) of HOAt and 265 mg 
(1.38 mmol, 1.2 equiv) of EDC
.HCl. The mixture was stirred for 1 h at 0°C and then 
145 μl (1.38 mmol, 1.2 equiv) of tBu-NH2 in 30 ml of anhydrous DCM were added 
dropwise.  The  stirring  was  continued  overnight.  Afterwards,  the  solvent  was 
removed under reduced pressure and the residue oil was dissolved in 16 ml of DCM. 
Then, 4 ml of tBu-NH2 were added and the solution was stirred for another 1 h. 
Finally, solvent was evaporated and product was eluted in flash chromatography 
with a gradient EP/EtOAc 2/1, 1/1, 1/2 1/3 affording 265 mg of a yellowish solid. 
Yield 85%. TLC: eluent EP/EtOAc 1/3, Rf 0.5; eluent CHCl3/EtOH 9/1, Rf 0.6. 
 
Mp: 124-126°C 
FT-IR (film, DCM) (cm
-1) 3395, 3321, 2969, 2928, 1648, 1519, 1452, 1363, 1228. 
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) δ 2.34 and 2.27 (two s, 2H), 1.85 and 
1.77 (two s, 2H), 1.50 and 1.44 (two s, 12H), 1.25 (s, 9H).  
ESI-MS C14H28N3O2 (MW = 270) m/z = 271 [M+H]
+     
 
Fmoc-Aib-TOAC-NHtBu 
 
To a suspension of 402 mg (1.24 mmol, 1.2 equiv) of Fmoc-Aib-OH in 10 ml 
of anhydrous DCM, were added 170 mg (1.24 mmol, 1.2 equiv) of HOAt and 240 mg 
(1.24 mmol, 1.2 equiv) of EDC
.HCl. The mixture was stirred for 1 h at 0°C and then 
280 mg of H-TOAC-NHtBu (1.03 mmol, 1 equiv) together with 180 μl (1.03 mmol, 1 
equiv) of DIEA were added. After 4 days of stirring, a lot of H-TOAC-NHtBu remained 
unreacted, thus a stronger coupling agent was employed. Indeed, Fmoc-Aib-F was 
used and prepared according to the following procedure: 200 mg of Fmoc-Aib-OH 
were suspended in 5 ml of anhydrous DCM at 0°C. Then  100 μl (1.23 mmol) of 
pyridine and 100 μl (1.23 mmoles) of cyanuric fluoride were added. After 2 h of 
stirring, the solution was washed with 3x50 ml of ice cold water and dried over 
Na2SO4. After 3 days of stirring, H-TOAC-NHtBu was still not completely reacted. 
Solvent was removed under reduced pressure and the residue was subjected to the 
following work-up: 2x50 ml of a 10% KHSO4 water solution, 30 ml of water, 2x50 ml 
of  a  5%  NaHCO3  water  solution,  50  ml  of  water  and  finally  dried  over  Na2SO4. 
Product was eluted with a gradient EP/EtOAc 5/1, 4/1, 3/1, 2/1, 1/1, 1/2 in flash 
chromatography. 190 mg of a yellowish solid were thus obtained in 60% of yield. 
Another 260 mg of product together with an impurity were recovered as well. TLC: 
Fmoc-Aib-TOAC-NHtBu, eluent CHCl3/EtOH 9/1, Rf 0.8. 
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Mp: 82-85°C 
FT-IR (film, DCM) (cm
-1) 3361, 2969, 2244, 1716, 1682, 1526, 1452, 1363, 1255, 
1085, 909, 740, 645, 618. 
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) δ 7.87-7.84 (m, 2H), 7.70-7.66 (m, 2H), 
7.45-7.36 (m, 4H), 7.18 (s, 1H), 6.98 (s, 1H), 6.69 (s, 1H), 4.41 (m, 2H), 4.35 (m, 1H), 
2.21 (m, 2H), 1.46 (s, 6H), 1.38 (s, 12H), 1.27 (s, 9H), 1.24 (m, 2H).  
ESI-MS C33H45N4O5 (MW = 577) m/z =  578 [M+H]
+     
 
 
Fmoc-(Aib)2-TOAC-NHtBu 
 
To a suspension of 123 mg (0.38 mmol, 1.5 equiv) of Fmoc-Aib-OH in 5 ml of 
anhydrous DCM at 0°C, were added 65 μl (0.75 mmol, 3 equiv) of cyanuric fluoride 
and 65 μl (0.75 mmol, 3 equiv) of pyridine. After 2 h of stirring, the solution was 
washed with 3x50 ml of ice cold water and dried over Na2SO4 and finally added to a 
solution of 90 mg (0.25 mmol, 1 equiv) of H-Aib-TOAC-NHtBu in 5 ml of anhydrous 
DCM. 66 μl (50 mg, 0.37 mmol, 1.5 equiv) of DIEA were added and stirring was kept 
for 4 days. Another 1.5 equivalents of Fmoc-Aib-F were introduced after the second 
day to consume quantitatively H-Aib-TOAC-NHtBu. Solvent was evaporated and the 
residue was washed with 2x50 ml of a 10% KHSO4 water solution, 30 ml of water, 
2x50 ml of a 5% NaHCO3 water solution and 50 ml of water to be finally dried over 
Na2SO4. Product was eluted with a gradient EP/EtOAc 5/1, 4/1, 3/1, 2/1, 1/1, 1/2, 
1/3 in flash chromatography. 100 mg (yield 72%) of a yellowish solid were thus 
obtained after crystallization from EtOAc/EP. TLC:  Fmoc-(Aib)2-TOAC-NHtBu, eluent 
CHCl3/EtOH 9/1, Rf 0.7. 
 
Mp: 213-215°C 
FT-IR (film, DCM) (cm
-1) 3348, 2975, 2244, 1675, 1526, 1444, 1357, 1262, 1093, 916, 
734, 645. 
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) 7.86-7.83 (m, 2H), 7.68-7.65 (m, 2H), 
7.44-7.34 (m, 5H), 7.25 (s, 1H), 7.11 (s, 1H), 6.83 (s, 1H), 4.31 (m, 3H), 2.22 (m, 4H), 
1.39 (m, 18H), 1.31 (s, 6H), 1.23 (s, 9H).  
ESI-MS C37H52N5O6 (MW = 662) m/z =  663 [M+H]
+         
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BzO-(CO)-CH2-NH-CHCH3-COOtBu
77 
 
20 ml of 1,4-dioxane together with 3 ml of DIEA (16.5 mmol, 3 equiv) were 
poured into  a  flask  and  then,  3  g  of  HCl
.H-Ala-OtBu  (16.5  mmol,  3  equiv)  were 
added. The mixture was cooled down to 0°C before adding dropwise over 1 h a 
solution of 1.26 mg of Br-CH2-CO-OBz (5.5 mol, 1 equiv) in 30 ml of 1,4-dioxane. 
Then, 10 ml of ACN were added and the stirring was continued for 3 days at r.t.. 
After solvent removal under reduced pressure, 100 ml of water were added and the 
product was extracted with 3x100 ml of EtOAc. The combined organic phases were 
gathered together and dried over anhydrous Na2SO4. Purification was carried out by 
flash chromatography using EP/EtOAc 4/1 as eluent. Finally, solvent was evaporate 
under reduced pressure to obtain 953 mg (yield 59%) of a colourless oil. TLC: BzO-
(CO)-CH2-NH-CHCH3-COOtBu, eluent EP/EtOAc 2/1, 0.4. 
 
FT-IR (film, DCM) (cm
-1) 3452, 3341, 2977, 2933, 1733, 1459, 1370, 1155, 748, 696. 
1H NMR (200 MHz, CDCl3) δ 7.35 (s, 5H), 5.16 (s, 2H), 3.56 (d, 1H), 3.45 (d, 1H) (2H), 
3.27 (q, J = 7 Hz, 1H), 2.05 (bs, 1H), 1.45 (s, 9H), 1.29 (d, J = 7 Hz, 3H). 
ESI-MS C16H23NO4 (MW = 293) m/z = 238 [M+2H-tBu]
+, 294 [M+H]
+. 
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HO-(CO)-CH2-NH-CHCH3-COOtBu
77 
 
In 50 ml of MeOH were put 191 mg of Pd/C 10% (20% w/w) and 953 mg 
(3.24 mmol) of BzO-(CO)-CH2-NH-CHCH3-COOtBu. The mixture was stirred for 2 hs 
under  H2  bubbling  until  disappearance  of  the  substrate  (TLC,  EP/EtOAc  1/1). 
Catalyst  was  removed  after  centrifugation  and  solvent  was  evaporate  under 
reduced pressure. The remaining oil was triturated with Et2O in order to obtain 457 
mg (yield 69%) of a white solid.  
 
Mp 168-171°C 
FT-IR (KBr) (cm
-1) 3458, 3060, 3004, 1739, 1627, 1586, 1502, 1376, 1251, 1159, 999, 
846, 741, 587, 524.  
1H NMR (200 MHz, MeOH-d4) δ 3.90 (q, J=7.01Hz, 1H), 3.47 (s, 2H), 1.50-1.46 (m, 
12H). 
ESI-MS C9H17NO4 (MW = 203) m/z = 148 [M+2H-tBu]
+, 204 [M+H]
+. 
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Fp-Ala-OtBu 
 
Similar derivatives are found in references
77,80. 340 mg (0.47 mmol, 1 equiv) 
of C60 were dissolved in 250 ml of toluene after 10 minutes of sonication and then, 
126 mg of HO-(CO)-CH2-CHCH3-COOtBu (0.61 mmol, 1.3 equiv) together with 71 mg 
(2.36 mmol, 5 equiv) of paraformaldehyde dissolved in 10ml MeOH were added. 
After 4 h of reflux, the purple mixture turned into brown. Reaction was monitored 
by TLC which showed the appearance of a spot with Rf 0.5 in toluene. The mixture 
was subjected to flash chromatography for purification using Toluene/EP 3/1 as 
eluent.  136  mg  (40%  w/w)  of  unreacted  C60  were  recovered.  Crystallization  by 
toluene/ACN afforded 193 mg (yield 46%) of Fp-Ala-OtBu as a brown solid. TLC: Fp-
Ala-OtBu, eluent toluene, Rf 0.6; eluent toluene/EP 7/3, Rf 0.3. 
 
FT-IR (KBr) (cm
-1) 3428, 2971, 1727, 1636, 1453, 1361, 1263, 1143, 750, 722, 575, 
525. 
1H NMR (200 MHz, CDCl3) δ 4.62 (s, 4H), 3.93 (q, J = 7 Hz, 1H), 1.76 (d, J = 7 Hz, 3H), 
1.64 (s, 9H). 
13C NMR (200 MHz, CDCl3) δ 172.08, 155.01, 147.32, 146.17, 145.41, 144.58, 142.63, 
141.91, 140.16, 136.40, 81.77, 70.21, 63.75, 59.90, 28.58, 16.90, 15.41. 
ESI-MS C69H17N1O2 (MW = 891) m/z = 892 [M+H]
+ 
 
 
Fp-Ala-(Aib)2–TOAC-NHtBu 
 
50 mg of Fp-Ala-OtBu (0.06 mmol, 1.2 equiv) were dissolved in 6 ml of CHCl3 
and 10 ml of TFA together with 250 μl of CF3SO3H were added. After 1 h of stirring 
at r.t., solvent and acid were removed under reduced pressure. The residue was 
washed several times with Et2O and dried under vacuum. TLC: Fp-Ala-OH, eluent 
Toluene/EtOAc 2/1, Rf 0.3; eluent CHCl3/EtOH 9/1, Rf 0.5. 30 mg of Fmoc-(Aib)2-
TOAC-NHtBu (0.05 mmol, 1 equiv) and 2 ml of DEA in 8 ml of ACN were stirred for 2 
hs  at  r.t.  Solvent  was  evaporated  and  the  residue  was  subjected  to  flash 
chromatography (eluent DCM, DCM/MeOH 9/1) to afford 19 mg (yield 97%) of H-
(Aib)2-TOAC-NHtBu.  Fp-Ala-OH was suspended in 30 ml of anhydrous CHCl3 and 10 
mg (0.07 mmol, 1.3 equiv) of HOAt and 14 mg (0.07 mmol, 1.3 equiv) of EDC
.HCl 
were added. The mixture was stirred for 1 h and then H-(Aib)2-TOAC-NHtBu in 5 ml 
of anhydrous CHCl3 together with 12 μl (0.07 mmol, 1.3 equiv) of DIEA were added. 
The mixture was stirred for 5 days at r.t. and then, solvent was removed under 
reduced pressure. The residue was washed with 2 ml of MeOH followed by 2 ml of 
toluene in a centrifuge tube. Finally, flash chromatography was performed using 
CHCl3, CHCl3/EtOH 200/1, 100/1, 70/1, 40/1, 25/1 as eluent to afford 10 mg (yield 
18%) of a brown solid. TLC: Fp-Ala-(Aib)2-TOAC-NHtBu, eluent CHCl3/EtOH 9/1, Rf 
0.6; eluent toluene/EtOH 8/1, Rf 0.2. 
HOOC-CH2-CHCH3-COOtBu
paraformaldehyde, 
toluene, reflux
O
O
N  38 
 
IR (1 mM, CHCl3) (cm
-1) 3456, 3436, 3357, 1670, 1514, 1458, 1380, 1363. 
1H NMR (500 MHz, CDCl3, 50 equivalents PH) 8.18 (s, 1H), 6.57 (s, 1H), 4.52 (m, 4H), 
3.8 (q, J = 7 Hz, 1H), 2.49 (m, 2H), 2.28 (m, 2H), 1.72 (d, J = 7 Hz, 3H), 1.60-1.52 (m, 
12H), 1.36 (s, 9H), 1.26-1.22 (m, 12H).   
MALDI-MS C88H49N6O6 (MW = 1257) m/z = 1258 [M+H]
+ 
UV-vis (CHCl3) λ (ε) 310 (23400), 430 (3000) 
 
 
 
2.4  Synthesis of fullerene-peptide-reference 2- 
 
Boc-(Aib)3-OMe 
 
The  Z  protecting  group  was  removed  under  catalytic  hydrogenation:  a 
mixture of 1 g of Z-(Aib)2-OMe (3.1 mmol, 1.2 equiv) and 200 mg of Pd/C 10% (20% 
w/w)  in  50  ml  of  MeOH  was  stirred  for  2  hs  under  hydrogen  bubbling. 
Disappearance of reagent was monitored by TLC (CHCl3/EtOH 14/1). Catalyst was 
discharged after centrifugation and solvent was evaporated under reduced pressure 
and under vacuum. TLC: Z-(Aib)2-OMe, eluent CH3Cl/EtOH 9/1, Rf 0.7; H-(Aib)2-OMe, 
eluent CHCl3/EtOH 9/1, Rf 0.4. 456 mg (2.6 mmol, 1 equiv) of Boc-Aib-OH, 389 mg 
(2.9 mmol, 1.1 equiv) of HOAt and 548 mg (2.9 mmol, 1.1 equiv) of EDC
.HCl in 5 ml 
of anhydrous DCM were stirred at r.t. for two hs before being poured into the flask 
containing H-(Aib)2-OMe (3.1 mmol, 1.2 equiv) dissolved in 5 ml of anhydrous DCM 
together with 445 μl (2.6mmol, 1 equiv) of DIEA. After 3 days of stirring at r.t., 
solvent was evaporated and the residue was washed with 3x50 ml of a 10% KHSO4 
water solution, 50 ml of water, 3x50 ml of a 5% NaHCO3 water solution, 50 ml of 
water  and  finally  dried  over  Na2SO4.  Solvent  was  evaporated  and  product  was 
crystallized from EP/EtOAc affording 255 mg (yield 25%) of  a white solid. TLC: Boc-
(Aib)3-OMe, eluent CHCl3/EtOH 9/1, Rf 0.6. 
 
Mp: 197-200°C 
FT-IR (KBr) (cm
-1) 3380, 3304, 2983, 2937, 1725, 1694, 1659, 1530, 1460, 1387, 
1314, 1170, 1083, 758, 650. 
1H NMR (200 MHz, CDCl3) δ 7.43 (s, 1H), 6.43 (s, 1H), 4.88 (s, 1H), 3.69 (s, 3H), 1.47 
(m, 27H).  
 ESI-MS C18H33N3O6 (MW = 387) m/z = 388 [M+H]
+ 
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Piv-(Aib)3-OMe 
 
To remove Boc protection, 245 mg (0.66 mmol, 1 equiv) of Boc-Aib3-OMe 
were dissolved in 2 ml of DCM together with 2 ml of TFA. After stirring for 1 h, 
solvent was evaporated under reduced pressure and under vacuum. TFA
.H-Aib3-
OMe thus obtained was dissolved in 20 ml of anhydrous DCM together with 230 μl 
of DIEA (1.32 mmol, 2 equiv). Then, a solution of 162 μl of Piv-Cl (1.32 mmol, 2 
equiv) in 5 ml of anhydrous DCM was added dropwise. The solution was stirred for 1 
day.  Solvent  was  removed  under  vacuum  and  the  residue  was  subject  to  flash 
chromatography (eluent, EP/EtOAc 1/3). 56 mg (yield 24%) of a white solid were 
obtained.  TLC: Boc-Aib3-OMe, eluent CH3Cl/EtOH 9/1, Rf 0.5. 
 
Mp:  175-177°C 
IR (KBr) (cm
-1) 3393, 3348, 3304, 2985, 1726, 1682, 1637, 1533, 1459, 1155, 756. 
1H NMR (200 MHz, CDCl3) δ 7.30 (s, 1H), 6.22 (s, 1H), 5.95 (s, 1H), 3.69 (s, 3H), 1.49-
1.47 (m, 18H), 1.21 (s, 9H). 
ESI-MS C18H33N3O5 (MW = 371) m/z = 372 [M+H]
+ 
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Piv-(Aib)3-OH 
 
56 mg (0.16 mmol, 1 equiv) of Boc-(Aib)3-OMe were dissolved in 0.8 ml of 
MeOH together with 0.8 ml of a 6 N water solution of NaOH (30 equiv). The solution 
was  stirred  for  2  days  and  then diluted  with  50  ml  of  EtOAc.  The  mixture  was 
washed with a 3x30 ml of a 10% KHSO4 water solution and with 2x30 ml of water. 
The  organic  phase  was  dried  over  Na2SO4  and  solvent  was  evaporated  under 
reduced pressure to afford 34 mg of a white solid (yield 60%).  
 
Mp: 235-238°C 
IR (KBr) (cm
-1) 3421, 3303, 3059, 3000, 1733, 1688, 1651, 1518, 1458, 1384, 1317, 
1233, 1206, 1169, 666. 
1H NMR (200 MHz, CD3CN) δ 7.52 (s, 1H), 6.87 (s, 1H), 6.66 (s, 1H), 1.46 (s, 6H), 1.38 
(s, 6H), 1.33 (s, 6H), 1.17 (s, 9H).  
ESI-MS C17H31N3O5 (MW = 357) m/z = 358 [M+H]
+ 
 
N
N
N
OMe
O
O
O H H
H
Piv N
N
N
OH
O
O
O H H
H
Piv
NaOH
 
Piv-(Aib)3-Ala-Fp 
 
44 mg (0.05 mmol, 1 equiv) of Boc-Ala-Fp were dissolved in 15 ml of DCM 
together with 15 ml of TFA.  
2) Boc-Aib-OH,
   EDC.HCl, HOAt, DIEA
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After  stirring  for  1  h  at  r.t.,  solvent  and  acid were  evaporated  and  the  residue 
washed with 4x30 ml of Et2O and then dried under vacuum. 22 mg (0.06 mmol, 1.3  
equiv) of Piv-(Aib)3-OH were dissolved in 5 ml of anhydrous CHCl3 and 11 mg (0.06 
mmol, 1.3 equiv) of EDC
.HCl were added. After stirring at r.t. for 1 h, the solution 
was cooled down to 0°C and poured in the flask containing H-Ala-Fp and 20 μl (0.18 
mmol, 3 equiv) of DIEA in 50 ml of anhydrous CHCl3. The mixture was stirred at r.t. 
for 7 days and then solvent was removed under reduced pressure. The residue was 
washed  with  2  ml  of  MeOH,  then  with  2  ml  of  toluene  in  a  centrifuge  tube. 
Subsequently,  flash  chromatography  was  performed  using  CHCl3,  CHCl3/EtOH 
200/1, 100/1, 50/1, 40/1 as eluent to afford 9 mg of a brown solid (yield 16%). TLC: 
Piv-(Aib)3-Ala-Fp, eluent CHCl3/EtOH 9/1, Rf 0.5; eluent toluene/EtOH 8/1, Rf 0.2. 
 
IR (1 mM, CHCl3) (cm
-1) 3437, 3329, 1662, 1512, 1456, 1380, 1362. 
1H NMR (200 MHz, CDCl3) δ 7.75 (d, 1H, J=8.1Hz), 7.51 (s, 1H), 6.20 (s, 1H), 5.97 (s, 
1H), 5.72 (m, 1H), 5.51 (m, 2H), 5.21 (m, 2H), 1.65-1.50 (m, 21H), 1.25 (s, 9H).  
13C NMR (50 MHz, CDCl3) δ 179.29, 174.98, 173.56, 173.08, 146.27, 145.39, 144.56, 
142.67,  142.13,  140.14,  129.04,  58.65,  57.57,  57.20,  56.91,  47.29,  27.38,  25.65, 
25.32, 17.63 
MALDI-MS C82H39N5O5 (MW = 1173) m/z =  1196 [M+Na]
+ 
UV-vis (CHCl3) λ (ε) 310 (24800), 430 (2700) 
 
2.6 Synthesis of fullerene-peptide 2+ reference 
 
Z-(Aib)3-NHtBu 
 
1 g (2.46 mmol, 1 equiv) of Z-(Aib)3-OH and 566 mg (2.95 mmol, 1.2  equiv) 
of EDC
.HCl were dissolved in 10 ml of DCM. Then, 3 μl (7.38 mmol, 3  equiv) of tBu-
NH2  were  added  and  the  solution  was  stirred  for  10  hs  at  r.t..  Solvent  was 
evaporated under reduced pressure and the residue was dissolved in EtOAc and 
washed with a 3x100 ml of a 10% KHSO4 water solution, 100 ml of water and finally 
dried over Na2SO4. Organic solvent was evaporated under reduced pressure and the 
residue was purified through flash chromatography using a gradient EP/EtOAc 1/1, 
1/2, 1/3, 1/4. Crystallization from EtOAc/EP afforded 813 mg (yield 72%) of a white 
solid. TLC: Z-(Aib)3-NHtBu, eluent CH3Cl /EtOH 9/1, Rf 0.4. 
 
Mp: 184-186°C 
FT-IR (KBr) (cm
-1) 3437, 3332, 2989, 2940, 1715, 1666, 1540, 1453, 1363, 1268, 
1226, 1167, 1094, 919, 730, 699, 618. 
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1H NMR (200 MHz, CDCl3) δ 7.35 (m, 5H), 7.08 (s, 1H), 6.72 (s, 1H), 6.27 (s, 1H), 5.39 
(s, 1H), 5.10 (s, 2H), 1.46 (s, 12H), 1.36-1.32 (m, 15H). 
ESI-MS C24H38N4O5 (MW = 462) m/z = 463 [M+H]
+ 
 
Fp-Ala-(Aib)3-NHtBu 
 
25 mg of Z-(Aib)3-NHtBu (0.05 mmol, 1.2 equiv) were dissolved in 50 ml of 
MeOH and 5 mg of Pd/C 10% (20% w/w) were added. The mixture was stirred for 2 
h under hydrogen bubbling and then centrifuged in order to remove the catalyst. 40 
mg (0.04 mmol, 1 equiv) of Fp-Ala-OtBu was dissolved in 15 ml of CHCl3 and 10 ml 
of TFA were added together with 250 μl of CF3SO3H. The mixture was stirred at r.t. 
for 1 h until complete disappearance of reagent (TLC: eluent toluene). Solvent was 
evaporated and the brown solid thus obtained was washed several times with Et2O 
and dried under vacuum. Subsequently, it was precipitated in 30 ml of anhydrous 
CHCl3, cooled down to 0°C and 8 mg (0.06 mmol, 1.3 equiv) of HOAt and 11 mg 
(0.06 mmol, 1.3  equiv) of EDC
.HCl were added. The mixture was stirred for 1 h and 
then H-(Aib)3-NHtBu (1.2 equiv) in 5 ml of anhydrous CHCl3 together with 5 μl (0.04 
mmol, 1  equiv) of DIEA were added. The mixture was stirred for 2 days and then, 
flash chromatography was performed using CHCl3, CHCl3/EtOH 200/1, 100/1, 70/1, 
40/1, 25/1 as eluent. 10 mg (yield 20%) of a brown solid were obtained. TLC: Fp-Ala-
(Aib)3-NHtBu, eluent CHCl3/EtOH 9/1, Rf 0.5, eluent toluene/EtOH 8/1, Rf 0.2. 
 
FT-IR (1 mM, CHCl3) (cm
-1) 3460, 3434, 3358, 1672, 1514, 1458, 1380, 1362. 
1H NMR (200 MHz, CD2Cl2) δ 8.17 (s, 1H), 7.32 (s, 1H), 6.74 (s, 1H), 6.35 (s, 1H), 4.56 
(s, 4H), 3.80 (q, J = 7 Hz, 1H), 1.76 (d, J = 7 Hz, 3H), 1.56-1.44 (m, 18H), 1.33 (s, 9H).  
13C NMR (50 MHz, CDCl3) δ 174.05, 172.82, 172.20, 153.92, 147.50, 146.32, 145.74, 
145.42, 144.62, 143.26, 142.83, 142.08, 140.39, 136.01, 69.78, 64.25, 60.73, 57.03, 
50.85, 28.76, 26.25, 25.45, 25.05, 15.33. 
MALDI-MS C81H39N5O4 (MW = 1145) m/z = 1146 [M]
+ 
UV-vis (CHCl3) λ (ε) 310 (23400), 430 (3000) 
 
2.9 Synthesis of peptide-reference 2- 
 
Piv-TOAC-(Aib)2-NHtBu 
 
To a solution of 20 mg of Piv-TOAC-(Aib)2-OH (0.04 mmol, 1 equiv) in 5ml of 
anhydrous ACN were added 10 mg of EDC
.HCl (0.05 mmol, 1.3 equiv).  
The solution was stirred at r.t. for 3 h and then 14 μl of tBu-NH2 (0.13mmol, 3.2 
equiv) were added. The solution was stirred at 70°C for 4 days, then the solvent was 
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evaporated under reduced pressure. The residue was dissolved in 10ml of DCM and 
washed with 2x10 ml of a 10% KHSO4 water solution, 10 ml of water, 2x10 ml of a 
5% NaHCO3 water solution and 10 ml of water to be finally dried over Na2SO4. 
Crystallization from EtOAc / Hexane afforded 9 mg of a yellowish powder (yield 
40%). TLC: Piv-TOAC-(Aib)2-NHtBu, eluent CHCl3 / EtOH 9/1, Rf 0.4. 
 
FT-IR (1 mM, CHCl3) (cm
-1) 3459, 3437, 3360, 1679, 1663, 1520, 1454, 1380, 1362.  
1H NMR (500 MHz, CDCl3, 10 equivalents PH) 6.98 (s, 1H), 6.69 (s, 1H), 6.63 (s, 1H), 
6.14 (s, 1H), 2.11 (m, 4H), 1.48 (s, 6H), 1.40 (s, 6H), 1.36 (s, 9H), 1.31 (s, 6H), 1.23 (s, 
15H). 
FAB-MS C27H50N5O5 (MW = 524) m/z = 525 [M+H]
+ 
 
2.10 Synthesis of peptide-reference 2+ 
 
Piv-(Aib)2-TOAC-NHtBu 
 
   7 mg of Fmoc-(Aib)2-TOAC-NHtBu (0.01 mmol, 1 equiv) and 2ml of DEA in 
8 ml of ACN were stirred for 1 h at r.t. Solvent and DEA were then removed under 
reduced pressure. The residue was dissolved in 2 ml of DCM and subjected to flash 
chromatography with CHCl3, CHCl3/EtOH 9/1 as eluent. H-(Aib)2-TOAC-NHtBu was 
dissolved in 2 ml of anhydrous DCM and 3 μl of Piv-Cl (0.02 mmol, 2 equiv) together 
with 2 μl of pyridine (0.02 mmol, 2.3 equiv) in 1ml of anhydrous DCM were added. 
The solution was stirred at r.t. for 1 day, then solvent was removed under reduced 
pressure. The residue was dissolved in 5ml of DCM and washed with 2x10 ml of a 
10% KHSO4 water solution, 10 ml of water, 2x10 ml of a 5% NaHCO3 water solution 
and 10 ml of water to be finally dried over Na2SO4. Crystallization from EtOAc / 
Hexane afforded 1.4 mg of a yellowish powder (yield 23%). TLC: Piv-(Aib)2-TOAC-
NHtBu, eluent CHCl3/EtOH 9/1, Rf 0.5. 
 
FT-IR (1 mM, CHCl3) (cm
-1) 3466, 3438, 3367, 1679, 1663, 1520, 1454, 1380, 1362. 
1H NMR (500 MHz, CDCl3, 50 equivalents PH) 6.27 (s, 1H), 5.91 (s, 1H), 2.46 (m, 2H), 
2.27 (m, 2H), 1.47, 1.32, 1.20. The assignments of the four NH protons was not 
possible due to the quencher signals. The aliphatic region was not clearly resolved. 
FAB-MS C27H50N5O5 (MW = 524) m/z = 525 [M+H]
+ 
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2.11 Synthesis of Boc-TOAC-NHtBu 
 
The starting material Boc-TOAC-OH was previously prepared according to 
procedure for the synthesis of Fmoc-TOAC-OH. To a suspension of 100 mg (0.32 
mmol, 1 equiv) of Boc-TOAC-OH in 20 ml of anhydrous DCM, were added  56 mg 
(0.41 mmol, 1.3 equiv) of HOAt and 79 mg (0.41 mmol, 1.3 equiv) of EDC
.HCl. The 
mixture was stirred for 1 h at 0°C and then 89 μl (0.8 mmol, 2.5 equiv) of tBu-NH2 in 
5  ml  of  anhydrous  DCM  were  added  dropwise.  The  stirring  was  continued 
overnight. Afterwards, the solvent was removed under reduced pressure and the 
residue oil was dissolved in 30 ml of EtOAc. The organic phase was washed with 
2x30 ml of a 10% KHSO4 water solution, 30 ml of water, 2x30 ml of a 5% NaHCO3 
water  solution,  30  ml  of  water  and  finally  dried  over  Na2SO4.  Solvent  was 
evaporated and product was crystallized from EP/EtOAc affording 97 mg  of an 
orangey solid. Yield 85%. TLC: eluent EP/EtOAc 1/1, Rf 0.5. 
 
1H-NMR (200 MHz, CD3CN/D2O 2/1, Na2S2O4) δ 6.81 (s, 1H), 2.26 – 2.19 (m, 2H), 
1.99 – 1.93 (s, 2H), 1.48 (s, 9H), 1.36 - 1.34 (s, 12H), 1.22 (s, 9H). 
ESI-MS C19H36N3O4 (MW = 370) m/z = 371 [M+H]
+   
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3. Results and discussion 
  
3.1 Synthetic approach 
 
                All the peptides were synthesized by standard solutions procedures adding 
one residue per time to the peptide chain. The t-butyl amides (t = tert) of the P-
protected peptides (P = protecting group) P-(aminoacid)3-NHtBu, are obtained by 
condensation  of  P-aminoacid-OH  with  the  appropriate  H-(aminoacid)n-1-NHtBu 
segments. Amide coupling between the N
α-deprotected peptides H-(aminoacid)3-
NHtBu with Fp-Ala-OH (Fp = fulleropyrrolidine), freshly prepared by hydrolysis of 
the t-butyl ester, affords Fp-Ala-(aminoacid)3-NHtBu. The carboxilyc acids of the Piv-
protected  peptides  (Piv  =  pivaloyl  or  tbutyl-carbonyl)  Piv-(aminoacid)3-OH,  are 
obtained  by  condensation  of  P-aminoacid-OH  (P  =  protecting  group)  with  the 
appropriate H-(aminoacid)n-1-OE segments (E = ester) followed by reaction with Piv-
Cl after removing of N
α-protection and final hydrolysis of ester.  Amide coupling 
between peptides Piv-(aminoacid)3-OH with H-Ala-Fp, freshly prepared by removal 
of  the  Boc  protection  (Boc  =  t-Butyloxycarbonyl),  yields  Piv-(aminoacid)3-Ala-Fp. 
Whereas  the  amino  function  was  protected  by  means  of  urethanes  (Z  = 
benzyloxycarbonyl, Fmoc = 9-fluorenylmethoxycarbonyloxy, Boc), methyl esters and 
t-butyl esters were used for the carboxylic function.  Activation of the carbonyl was 
carried out employing EDC
.HCl / HOAt. In some case, cyanuric fluoride was also 
used.  Unlike Ala, Aib and TOAC are achiral aminoacids so that no racemization issue 
were taken into account. On the other hand, their steric hindrance is responsible for 
prolonged  reaction  times  and  low  yields  compared  with  other  less  hindered 
aminoacids.  The  functionalization  of  C60  was  performed  by  the  Maggini-Prato 
reaction,  by  decarboxylating  the  condensation product  of  N-substituted  glycines 
with formaldehyde. The 1,3 dipole thus obtained in situ is trapped by the fullerene 
in a [3+2] cycloaddition giving N-substituted-3,4-fulleropyrrolidines. 
 
3.1.1 Protection of the amino group 
 
              Fmoc is the only urethane that can be utilized when TOAC is present. Fmoc 
is removed using DEA 50% v/v and TOAC is stable under basic conditions as its 
synthesis can suggest. The removal conditions for the Z group are not compatible 
with the free radical which would be reduced after the catalytic  hydrogenation. TFA 
50% v/v cleaves the Boc moiety but, it is known that under acidic conditions, TOAC 
undergoes a disproportion process leading to two derivatives. The oxidated product 
was found to be an oxidating agent
82. 
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Figure 3.1 Disproportion products of TOAC under acidic conditions.   46 
Besides, Fmoc-tagged amino acids are easy to follow under UV lamp thanks to the 
fluorenyl cromophore. However, this urethane owns two disadvantages. Not only 
the coupling conditions (presence of a free primary amine) are not so different from 
the  deprotecting  conditions  but  also  the  side  product  of  the  deprotection, 
dibenzofulvene, is a mild electrophile which must be disposed of, thus introducing a 
further step of work. Z group was used during the synthesis of peptides-references 
instead. Z derivatives are fairly stable and easy to follow under UV lamp. Boc group 
was employed when C60 was present since acidic conditions are compatible with 
fullerene, unlike catalytic hydrogenation and basic conditions. Indeed, C60 is reactive 
towards nucleophiles such as primary and secondary amines.  
 
3.1.2 Protection of the carboxylic function 
 
               In analogy to Boc, t-butyl ester was exploited because it can be hydrolyzed 
under acidic conditions. Methyl ester was used during the synthesis of Piv-(Aib)3-OH 
since it can be hydrolyzed under basic conditions which are orthogonal to the Z and 
Boc groups.  
 
3.1.3 Carboxyl activation 
 
             In this work, the formation of the amide bond is catalyzed by the couple 
EDC
.HCl / HOAt.  
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Figure 3.2 Chemical structure of EDC
.HCl (on the left) and HOAt (on the right). 
 
The  carbodimide  promotes  the  formation  of  an  activated  ester  intermediate 
between  the  carboxylic  group  of  the  N
α-protected  and  the  HOAt.  The  catalytic 
effect of the HOAt is due to the anchimeric assistance given to both nitrogen atoms 
N2 and N7 for nucleophilic attack to the amine group
83. 
 
Figure 3.3 Nucleophilic attack assisted by HOAt that activates the carboxylic 
group.   47 
               In some case, a stronger activating agent was employed. Cyanuric fluoride 
is a mild fluorinating agent able to transform carboxylic acids in acyl fluorides
84.  
 
Figure 3.4 Chemical structure of cyanuric fluoride. 
 
Acyl fluorides are stable in presence of t-butyl, Boc, Fmoc, Trityl protection and are 
greater stable than the corresponding acyl chlorides to exposition to water. Besides, 
they  do  not  undergo  fast  cyclization  to  oxazolone  (Leuch’s  anhydride)  such  as 
Fmoc/Boc N-protected aminoacid bromides
85 do. This effect is even more facilitated 
with  Aib  by  the  presence  of  the  two  α-methyl  substituents  (”gem-dimethyl 
effect”)
84. Thus, different protecting groups than urethanes must be used when acyl 
bromide /chloride are to be employed.  
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Figure 3.5 The oxygen of the carbonyl group of Boc attacks the acyl bromide to give 
the oxazolone.  
 
3.1.4 N-substituted-3,4-fulleropyrrolidines 
 
                There  are  several  ways  to  functionalize  the  fullerene  exploiting  its 
tendence  to  behave  like  a  reactive  2π  component  in  cycloaddition
1.  The  [6,6] 
double bonds are dienophilic which enables the molecule to form five-membered 
rings covalently through [3+2] cycloadditions with 1,3 dipolarophiles
1. Azomethine 
ylides are 1,3 dipoles, planar species, which can be easily generated in situ from 
several readily accessible materials obtained by decarboxylating the condensation 
product of N-substituted glycines with formaldehyde
41,73,86. The broad acceptance 
of this method (the Maggini-Prato reaction) is explained by the good selectivity 
(only the 6,6 bond is attacked) and a wide range of addends and functional groups 
that  are  tolerated
1,41.  Other  methods  were  not  suitable  to  the  synthesis  of  our 
systems  either  because  strong  conditions  are  required  (e.i.  Bingel  reaction),  or  
because  complicated  equilibrium  between  the  [6,5]-open  and  [6,6]-closed 
structures of [60]fullerene takes place (e.i. addition-thermal decomposition of diazo 
compounds)
1. Furthermore, the Maggini-Prato reaction does not require particular 
functional groups, to stabilize the intermediate responsible for the cycloaddition,  
that can interfere with the electrochemical investigation and allows us to obtain the 
fullerene-peptides 2+ and 2- only by modifying the substituent at the nitrogen atom 
of glycine.  
N
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Indeed in the reaction, the amino function of an N-substituted glycine attacks the 
carbonyl group of the aldehyde giving the corresponding imine. Subsequently, the 
oxygen  O-H  of  the  carboxyl  function  attacks  the  carbon  of  the  imino  function 
affording  the  oxazolidinone  which  can  be  isolated  in  the  case  of  3-trityl-5-
oxazolidinone
73.  Under  refluxing  toluene,    the  oxazolidinone  intermediate 
decarboxilates  thus  generating  the  1,3  dipole  which  is  trapped  by  the  C60.  The 
cycloaddition product is an N-substituted pyrrolidine ring covalently linked to the 
C60.  
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Figure 3.6 Generation of azomethine ylide. 
 
Nucleophilic  substitution  of  Bromo-benzyl-acetate  by  H-Ala-OtBu,  followed  by 
catalityc hydrogenation of the benzyl ester, gives the corresponding N-substituted 
glycine in 68% of yield. 1 equivalent of this derivative together with 5 equivalents of 
paraformaldehyde and 1 of C60 under refluxing toluene for 3 hours affords Fp-Ala-
OtBu  in  45%  of  yield.  When  Trt-Gly-OH  (Trt  =  triphenylmethyl)  is  mixed  with 
aqueous formaldehyde in EtOH, 3-trityl-5-oxazolidinone
73 is produced and can be 
isolated  and  used  for  the  cycloaddition  with  C60.  The  product  is  a  3,4-
fulleropyrrolidine protected at the nitrogen atom with the trityl moiety. Removal of 
the trityl moiety followed by amide coupling with (Boc-Ala)2O affords Boc-Ala-Fp
75 
in 35% of overall yield.  
              Trityl,  Boc  and  t-butyl  ester  were  chosen  to  protect  the  amino  and 
carboxylic function because they can be removed under acidic condition. In fact, C60 
is not compatible with basic conditions
74,107 employed to hydrolyze methyl esters. It 
is known that C60 is reactive towards nucleophiles such as cyanide
23, amines
4,74, 
hydroxide
87. In case of secondary and primary amines, the addition starts with a 
single electron transfer to give the C60 radical anion, followed by the covalent bond 
formation  and  proton  transfer
74.  N-propylamine,  n-dodecylamine,  tbutyl-amine, 
ethylenediamine,  morpholine  have  been  observed  to  react  with  neutral  C60  in 
solution  to  give  amino  addition  compounds  of  the  type  C60Hn(NRR
’)
88.  Neither 
catalytic  hydrogenation  used  to  remove  benzyl  esters  can  be  applied  when  the 
fullerene is present.  
 
 
3.2 The fullerene-Aib-peptide and the attempts for its 
synthesis 
 
              The  synthesis  of  a  fullerene-peptide,  where  the  alanine  residue  was 
originally an Aib residue, was also attempted.     49 
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Figure 3.7 Fullerene-Aib-peptide 2- (on the left) and 2+ (on the right). 
 
Peptide synthesis employing Aib is characterized by long time reactions and low 
yields  because  of  the  high  steric  hindrance  at  the  α-carbon.  In  this  case,  the 
coupling is even more challenging because the nitrogen of fulleropyrrolidine is not a 
good  nucleophile  due  to  the  inductive    and  steric  effect  brought  about  by  the 
buckyball
109. Many strategies were tried out but no one could afford the desired 
products fullerene-Aib-peptide 2- and 2+. This strategies will be now described in 
detail: 
 
-nucleophilic attack to the saturated carbon of α-bromoamides 
-use of activated ester and anhydride 
-use of acyl chloride/bromide 
-novel strategy through fulleroproline 
 
3.2.1 Nucleophilic attack to the saturated carbon of α-
bromoamides 
 
               It  is  known  that  in  2-bromoamides,  the  bromine  can  be  displaced  by 
nucleophiles through an SN2 mechanism bringing the configuration at the α-carbon 
inverted. When silver oxide Ag2O is added, the reaction rate speeds up and no 
inversion is observed. It was postulated that Ag2O behaves both as Lewis acid and 
Bronsted base because from one hand, Ag weakens the Br-C
α bond and on the 
other, the oxygen contributes to break the N-H bond thus generating an aziridonic 
intermediate which is very reactive and undergoes attack by the nucleophile
89,90,91.  
 
 
Figure 3.8 Nucleophlic substitution at the α-carbon in 2-bromoamides promoted by 
silver oxide. The retention of the configuration at the α-carbon is explained invoking 
the mechanism depicted above. 
 
Even silver triflate Ag
+CF3SO3
- is able to catalyse this reaction with the difference 
that it promotes the configuration inversion at the α-carbon
91. 
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 The synthesis of derivatives 1 and 2 (Figure 3.9) was attempted according to the 
synthetic  strategic  described  before  regarding  the  nucleophilic  attack  at  the  α-
carbon of 2-bromoamides. 
 
Figure 3.9 Derivative 1 (on the left) and derivative 2 (on the right). 
 
               Derivative  1  and  2  (Figure  3.9)  are  respectively  the  precursors  for  the 
synthesis of fullerene-Aib-peptides 2- and 2+ where the R group can be a removable 
group or the peptides itself. In order to obtain the derivative 1, the following route 
was followed. Firstly, reaction between fulleropyrrolidine and α-bromo-α-dimethyl-
acylbromide afforded Br-Aib-Fp in quantitative yield.   
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Figure  3.10  Reaction  between  fulleropyrrolidine  and  Br-isobutyric-acylbromide 
afforded Br-Aib-Fp. 
 
Secondly,  because  Br-Aib-Fp  is  a  tertiary  α-bromo-amide  which  can  in  principle 
undergo nucleophilic attack at the α-carbon promoted by silver triflate, ammonia 
and Trt-NH2 were used as nucleophiles. Trt-NH2 was also employed in the place of 
NH3 because: 
 
-it is more soluble in toluene than NH3 
-it is a solid and its concentration can be controlled 
-in case derivative 1 was obtained, the amino group was protected by the trityl 
moiety which can be removed under acidic condition 
 
              To a solution of 20 mg of fulleropyrrolidine (0.03 mmol, 1 equiv) in 50 ml of 
toluene at 0°C were added 10 μl (18 mg, 0.08 mmol, 3 equiv) of BrC(CH3)2COBr. 
After stirring for 1 h at r.t., solvent was evaporated under reduced pressure and the 
residue  was  subjected  to  flash  chromatography  using  toluene  as  eluent.  23  mg 
(quantitative yield) of Br-Aib-Fp as a brown solid were thus obtained. TLC Br-Aib-Fp, 
eluent toluene, Rf 0.3. 
1H NMR (200MHz, CDCl3) δ 5.68 (s, 4H); 2.27 (s, 6H). 20 mg 
(0.02 mmol, 1 equiv) of Br-Aib-Fp and 23 mg (0.11 mmol, 5 equiv) of AgClO4 were 
dissolved in 50 ml of toluene and the solution was bubbled at r.t. with ammonia gas 
generated mixing 50 g of NaOH and 67 g of NH4Cl in another flask. The gas flow was 
forced to pass through two tubes containing NaOH pallets and anhydrous NaSO4 to 
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remove water traces. Even after 20 days of bubbling under stirring at r.t. and 1 day 
at  60°C,  no  reaction  took  place  since  Br-Aib-Fp  was  recovered  after  flash-
cromatography unchanged (as 
1H NMR spectrum demonstrated).  
 
Figure 3.11 Reaction scheme for the synthesis of H-Aib-Fp. 
 
                  When a toluene solution of 20 mg of Br-Aib-Fp (0.02 mmol, 1 equiv) and 
11 mg (0.04 mmol, 2 equiv) of Trt-NH2 together with 40 mg (0.13 mmol, 6 equiv) of 
SilverTriflate  (Triflate  =  CF3SO3
-)  was  refluxed  for  two  days,  Br-Aib-Fp  was 
quantitatively  transformed  into  product  (TLC,  eluent  toluene/EtOAc  9/1). 
Unfortunately, 
1H-NMR spectrum revealed that the product was not derivative 1 
but  the  corresponding  unsatured-α,β-amide.  TLC  product,  eluent  toluene/EtOAc 
9/1, Rf 0.4.  
1H NMR (200MHz, CDCl3) δ 5.59 (s, 2H), 5.47 (s, 4H), 2.21 (s, 3H). 
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Figure 3.12 Reaction scheme for the synthesis of Trt-Aib-Fp. The reaction gave the 
unsatured-α,β-amide. 
 
                 In  order  to  obtain  derivative  2  (Figure  3.9)  instead,  Fp-Aib-NHR, 
fulleropyrrolidine was stirred together with 2-Br-N-benzyl-propanamide in presence 
of silver oxide.  
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Figure 3.13 Reaction between 2-Br-N-Benzyl-propanamide was expect to give the 
corresponding substitution product Fp-Ala-NHBenzyl. 
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                  To  a  4  ml  toluene  solution  of  50  mg  (0.06  mmol,  3  equiv)  of 
fulleropyrrolidine, 20 mg (0.09 mmol, 4 equiv) of Ag2O and 5 mg (0.02 mmol, 1 
equiv) of 2-Br-N-Benzyl-propanamide were added. After 3 weeks of sonication at r.t. 
no product was detected on TLC employing toluene/EtOAc 1/1 and EP/EtOAc 1/1 as 
eluents. Same negative outcome was reached when 2-Br-N-Benzyl-butyramide was 
used. To a 5 ml toluene solution of 20 mg (0.03 mmol, 1 equiv) of fulleropyrrolidine, 
12 mg (0.05  mmol, 2 equiv) of Ag2O and 13 mg (0.05 mmol, 2 equiv) of 2-Br-N-
Benzyl-butyramide  were  added.  Product  was  detected  only  after  3  weeks  of 
sonication at r.t. and flash chromatography was performed for purification using 
toluene/EtOAc  9/1  as  eluent.  Unfortunately,  protonic  NMR  spetrum  showed  no 
compatible peak with the expected product Fp-Aib-NHBenzyl.  
               These  attempts  were  carried  out  to  see  if  the  strategy  employing  2-
bromoamides was feasible for the synthesis of fullerene-peptide 2+ according to 
the following reaction scheme: 
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Figure 3.14 Reaction scheme for the synthesis of fullerene-peptide 2+ through the 
nucleophilic substitution at the α-carbon of α-bromo-amides assisted by silver oxide. 
 
3.2.2 Use of the activated ester and anhydride 
 
              The synthesis of derivative 1 (Figure 3.9), P-Aib-Fp (P = protecting group), 
was attempted also using the activating couple EDC
.HCl / HOAt. To a suspension of 
15 mg (0.08 mmol, 1.2 equiv) of Boc-Aib-OH in 5 ml of anhydrous DCM at 0°C, 17.4 
mg (0.09 mmol, 1.4 equiv) of EDC
.HCl and 12 mg (0.09 mmol, 1.4 equiv) of HOAt 
were added. After stirring at r.t. for 1 h, the solution was added to a 50 ml toluene 
solution of 50 mg (0.06 mmol, 1 equiv) of fulleropyrrolidine together with 16 μl 
(0.09 mmol, 1.4  equiv) of DIEA. After stirring for 1 week at r.t. and 1 week at 60°C, 
no product was detected on TLC  (TLC, eluent toluene, EtOAc 9/1). The amide bond 
formation between Aib and fulleropyrrolidine was also attempted by using (Boc-
Aib)2O. To a suspension of 26 mg (0.13 mmol, 2 equiv) of Boc-Aib-OH in 5 ml of 
anhydrous DCM at 0°C, 15 mg (0.08 mmol, 1.2 equiv) of EDC
.HCl were added. After 
stirring at 0°C for 30 minutes and 2 hs at r.t., the solution was added to a 50 ml 
toluene solution of 50 mg (0.06 mmol, 1 equiv) of fulleropyrrolidine together with   53 
22 μl (0.13 mmol, 2 equiv) of DIEA. After stirring at r.t. for 1 week, no product was 
detected on TLC using toluene/EtOAc 9/1 as eluent.  
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Figure 3.15 Reaction scheme for the synthesis of Boc-Aib-Fp through the activated 
ester (A) and anhydride (B). 
 
3.2.3 Use of acyl chloride / bromide 
 
               Cyanuric fluoride was also employed to activate the carboxylic function of 
Aib in order to obtain Boc-Aib-Fp. To a suspension of 20 mg (0.10 mmol, 1.5 equiv) 
of Boc-Aib-OH in 5 ml of anhydrous DCM at 0°C, were added 43 μl (40 mg, 0.29 
mmol, 4.5 equiv) of cyanuric fluoride and 43 μl (23 mg, 0.29 mmol, 4.5  equiv) of 
pyridine. After 2 hours of stirring at r.t., the solution was washed with 3x50ml of 
iced water and dried over NaSO4 and finally added to a solution of 50 mg (0.06  
mmol, 1 equiv) of Fp in 50 ml of toluene together with 17 μl (0.10 mmol, 1.5  equiv) 
of  DIEA.  After  stirring  at  r.t.  for  1  h,  product  was  separated  through  flash 
chromatography however protonic NMR revealed no peak compatible with Boc-Aib-
Fp. 
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Figure 3.16 Reaction scheme for the synthesis of Boc-Aib-Fp through acyl fluoride. 
 
             Fmoc/Boc  N-protected  aminoacids  bromide/chloride  undergo  fast 
cyclization and therefore require particular N-protections such as sulfonamides and 
azides
85.  
 
O2N S
O O
N
H
R
-N
N+N
R
 
 
Figure 3.17 “o-Nbs” orto-nitro-sulphonamide (on the left) and azide (on the right). 
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These protecting groups are not able to take part in the cyclization as urethanes 
do
85. They can be respectively introduced using o-Nbs
106 chloride and CF3-SO2-N3
85. 
Then, the carboxylic group of the amino acid can be treated with 1-bromo-N,N-2-
trimethyl-1-propenylamine
92  to  be  transformed  into  the  corresponding  acyl 
bromide.  
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Figure 3.18 1-bromo-N,N-2-trimethyl-1-propenylamine is the brominating agent. P is 
the protecting group. 
 
                 Removal  of  o-Nbs  can  be  accomplished  after  exposition  to 
K2CO3/thiophenol in DMF whereas the azide group is transformed into the amino 
group after reduction with Ph3P in THF
85. The synthesis of an N3-Aib-Br or o-Nbs-
Aib-Br was not attempt because: 
 
- the synthesis of the brominating agent is not an easy task
92 
-  the  removal  condition  of  N3  and  o-Nbs  have  never  been  tried  in  presence  of 
fullerene 
- fulleropyrrolidine is not soluble in DMF and THF, solvents required during the 
deprotection step 
 
3.2.4 A novel strategy through fulleroproline 
 
                The experimental outcomes demonstrate that the amide bond formation 
between Aib and fulleropyrrolidine  can not be obtained by means of the synthetic 
routes  described  before.  Thus,  the  design  of  the  fullerene-Aib-peptides  was 
modified in the following way: 
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Figure 3.19 Modified fullerene-peptides 2+ (on the right) and 2- (on the left). The 
peptide is attached to the C60 moiety through a fulleroproline residue. 
 
             The  idea  was  to  synthesize  Fpr-OtBu  (Fpr=fulleroproline)  and  then  to 
hydrolyze the t-butyl ester to get Fpr-OH. Fpr-OH could react with the N-terminal 
peptide to give the fullerene-Aib-peptide 2+.  
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Besides Fpr-OH has a carboxylic function which can be converted into a primary 
amino group via Curtius rearrangement (Figure 3.25), to afford N-methyl-2-amino-
3,4-fulleropyrrolidine Fpr-NH2. Subsequently, Fpr-NH2 could react with the COOH-
terminal peptide to give the fullerene-Aib-peptide 2-. 
Figure 3.20 The strategy through fulleroproline. 
 
               3,4-fulleropyrrolidine has a secondary amino group whereas Fpr-NH2 bears 
a  primary  amino  group.  Therefore,  the  peptide  coupling  between  the  COOH-
terminal  peptide  and  Fpr-NH2  was  expected  to  be  easier,  compared  with  the 
coupling between fulleropyrrolidine and Aib, because less hindered.  
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                According to the experimental part described in the references
93,94, the 
following was the synthetic strategy tried to get the fullerene-peptide 2+ and 2- 
through fulleroproline:  
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Figure 3.21 Strategy for the synthesis of modified fullerene-peptide 2-. 
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Figure 3.22 Strategy for the synthesis of the modified  fullerene-peptide 2+. 
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Fpr-OtBu and Fpr-OH were synthesized as previously reported
95,96.  
 
paraformaldehye, 
Sarcosine tBu ester
Toluene reflux, 1.5h
O N
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Figure 3.23 Reaction scheme for the synthesis of Fpr-OtBu. 
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Figure 3.24 Reaction scheme for the synthesis of Fpr-OH. 
 
N-methyl-2-amino-3,4-fulleropyrrolidine 
 
250 mg (0.30 mmol, 1 equiv) of Fpr-OH were suspended in a 200 ml solution 
of DCM/dioxane 1/1. 25 ml (300 mmol, 1000 equiv) of Cl2SO were added and the 
mixture was refluxed for 24 hs. Solvent and thionyl chloride in excess were removed 
under  vacuum.  200  mg  (0.24  mmol,  1  equiv)  of  the  residue  were  subsequently 
suspended in 20 ml of toluene at 0°C and treated with 197 μl (0.71 mmol, 3 equiv) 
of Bu3SnN3 dropwise according to the experimental part of reference
94. The mixture 
was stirred for 2 days at r.t. and the solvent remained uncoloured, then refluxed for 
1 day in presence of 5 ml of water to decompose the expected azide. Solvent was 
removed under reduced pressure but unfortunately the residue was not soluble in 
any solvent so that it was not possible to characterize the product. The synthetic 
project of the fullerene-peptide 2+ and 2- through fulleroproline was thus rejected. 
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Figure 3.25 Reaction scheme followed to try to obtain the derivative N-methyl-2-
amino-3,4-fulleropyrrolidine via Curtius rearrangement .   59 
3.3 Investigation and Characterization in solution 
 
                The fullerene-peptides were found to be soluble in chlorinated solvents 
such  as  CHCl3  and  1,2-dichloroethane.  The  solubility  slightly  decreases  in  DCM. 
However,  these  molecules  are  insoluble  in  more  polar  solvents  or  toluene.  The 
synthesized  molecules  were  characterize  by  mass  spectrometry,  FT-IR  and  NMR 
spectroscopies.  The  mass  spectra  show  the  expected  molecular  peak  for  both 
fullerene-peptides 2+ and 2- (Figures 3.26 a, b). The analyte was dissolved in CCl4 
containing DCTB to obtain a 0.1 mM solution with a 1:1000 analyte/matrix ratio. 2 
μL of solution were drop-cast onto the sample plate and air-dried. The spectra were 
recorded by MS-Reflector mode in the positive mode.  
Figure 3.26 a. MALDI –TOF mass spectrum of fullerene-peptide 2-.  
 
Figure 3.26 b. MALDI-TOF mass spectrum of  fullerene-peptide 2+.  
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3.3.1 FT-IR characterization of the 2+ and 2- systems 
 
               FT-IR  absorption  spectra  were  recorded  in   CHCl3  at  23°C    which    is   a  
solvent  of  low  polarity  having  no propensity  to  behave  as  a  hydrogen-bond  
acceptor,  and  the analysis focused on the N - H and C = O stretching modes. The N 
- H stretching region (amide A, 3500 ÷ 3200 cm
-1) is composed by a high-energy 
region corresponding to the NH groups that are not involved in hydrogen bonds and 
a low-energy region pertaining to NH groups involved in intra- and inter-molecular 
hydrogen  bonds
99.  For  the  amide  A  stretching  region,  the  FT-IR  spectra  of  the 
investigated systems (Figure 3.27 a) reveal a strong absorption band in the range 
3369 ÷ 3329 cm
-1 and a weaker band at 3469 ÷ 3439 cm
-1 assigned to N-H bonded 
and N-H free groups, respectively 
97.  
                Information  on  peptide  conformation  is  also  found  in  the amide I and 
amide II regions. Amide I, which corresponds to the C = O stretching, occurs at 1662 
÷ 1666 cm
-1 for fully stable 310-helices, whereas the amide II band, which is more 
complex with  an  important  contribution  from  N-H  bending  and  C-N  stretching 
vibrations, is expected at 1531 ÷ 1533 cm
-1 99 for fully  formed 310-helices. In the 
amide I region, a strong band in the range 1678 ÷ 1662 cm
-1 is observable in figure 
3.27 b, typical for the carbonyl in helical peptides
98. The systems 2+ and 2- possess 4 
NH groups belonging to tetrasubstituted residues (Aib, TOAC) and in a previous IR 
absorption study, it was possible to show that Aib homooligomers with 4 NH groups  
are characterized by 69% of intramolecular H-bonds of the 310 -helix type
60. These 
data highlight the great efficiency of the Aib unit in stabilizing folded and helical 
species even in very short peptides
99. 
             Now we will focus on the comparison among the various spectra. The IR 
spectra in figures 3.27 a, b clearly disclose the similarity of the fullerene-peptide 2+ 
with  its  fullerene-peptide-reference  and  its  peptide-reference.  Noteworthy, 
however,  a  marked  difference  is  evident  in  the  free  NH  band  for  the  peptide-
reference 2+ which results more intense in comparison with the free NH band for 
the  fullerene-peptides  2+  and  fullerene-peptide-reference  2+:  this  suggests  a 
possible deviation on the number of free NH groups. Unlike the 2+ series, the peak  
position of the fullerene-peptides 2- spectrum does not match those of the spectra  
of  the  fullerene-peptide-reference  2-  and  peptide-reference  2-  in  the  amide  A 
region. Whereas the free NH band occurs at the same wavenumber for the three 
compounds, a red shift is observable for the bonded NH band as one goes from the 
peptide-reference, to the fullerene-peptide and to the fullerene-peptide-reference. 
It  appears  that  the  interactions  involving  the  NH  groups  in  the  2-  series  are  of 
different strenght. This observed increase in bond strength for the bonded NH could 
be accounted for by two reasons. Firstly, in the 2- series, the negative pole of the 
macrodipole  is  on  the  fullerene,  which  is  known  to  be  electro-deficient
1,6a.  In 
principle,  C60  should  not  influence  the  peptide  helical  structure  as  previously 
observed in other reports
75,105 but in this particular case, a strong oriented dipole 
moment  is  located  along  the  main  axes  of  the  compound.  Preliminary  results 
obtained on the experimental determination of the dipole moments of series of Aib 
homooligomers indicated that the peptide dipole moment linearly increases with 
the number of Aib units. This outcome also implies that these peptides are indeed 
stiff even when short.   61 
For peptides with one, two and three intramolecular hydrogen bonds, 8.22, 10.79 
and 12.34 D were determined, respectively
120. Therefore, by helping to spread the 
negative charge density of the negative side of the macrodipole, the C60 moiety 
could play a role in the stabilization of the peptide secondary structure. Secondly, it 
appears that in the minus series, the substitution of the TOAC residue with an Aib 
residue brings about an effect on the NH groups interaction frameworks displayed 
by the red shift of the bonded NH in the FT-IR spectra of fullerene-peptide 2- and 
fullerene-peptide-reference 2-. The absence of any band shift in the FT-IR spectra of 
the plus series would thus point to a higher sensitivity of the peptide secondary 
structure  of  the  minus  series,  compared  with  the  plus  series,  to  change  of  the 
chemical surround. 
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Figure 3.27 a. FT-IR spectrum of systems 2+ and 2- in the amide A stretching region. 
2- system in dashed line. 2+ system in continue line. Fullerene-peptide, fullerene-
peptide-reference, peptide-reference. Spectra are normalized by taking into account  
the N-H band of intramolecularly H-bonded peptides. 
Figure 3.27 b. FT-IR spectrum of systems 2+ and 2- in the amide I and II stretching 
region.  2-  system  in  dashed  line.  2+  system  in  continue  line.  Fullerene-peptide, 
fullerene-peptide-reference,  peptide-reference.  Spectra  are  normalized  by  taking 
into account the C=O band.   63 
3.3.2 
1H NMR characterization of fullerene-peptides-
reference 2+ and 2- 
 
                           1H NMR of 2 mM fullerene-peptides-reference 2- and 2+  (Figures 3.30 
and 3.31) were acquired at r.t. using CDCl3 as the solvent. CD2Cl2 however, was 
employed  for  the  fullerene-peptide-reference  2+  because  one  signal  perfectly 
overlaps with the signal of the residual CHCl3 when CDCl3 is used.  
                  
13C NMR spectra of 3 mM fullerene-peptides-reference 2+ and 2- in CDCl3 
show a cluster of peaks in the aromatic region 153 ÷ 136 ppm, typical of fullerene 
carbons
22.  
                  Being  CHCl3  the  only  solvent  that  reasonably  dissolves  the  fullerene-
peptides, circular dichroism measurements can not be exploited to obtain structural 
information because any absorptions under 220 nm is covered. However, above 220 
nm no otpically active band was observed for the fullerene-peptide-reference 2+ in 
a 1 mM CHCl3 solution.  
                 2D ROESY (Rotating-Frame Overhauser Effect Spectroscopy) spectra and 
1H  NMR  titrations  were  performed    to  obtain  information  on  the  secondary 
structure  assumed  by  the  fullerene-peptides  in  solution.  Bidimensional 
1H  NMR 
spectra of the fullerene-peptides-reference 2+ and 2- were obtained in CDCl3 and 
allowed for complete proton assignment. Through-space connectivities of the C
βH (i 
- 1) → NH (i) type (between the methyl protons of an Aib and the amide proton of 
the following residue) and NH (i) → NH (i + 1)  type  were  used  for  the  assignment  
of    the    proton  resonances.  In  particular,  it  was  possible  to  determine 
unambiguously  the  identity  of  the  four  amide  protons  both  for  the  fullerene-
peptides-reference  2+  and  2-.  By  providing  information  on  the  through-space  
connectivities,  useful  insights  into  the  peptide  secondary  structure  could  be 
obtained. The  section  of  the  ROESY  spectrum  of  fullerene-peptides-reference 2- 
and  2+    in    figures  3.33  a,  b  and  3.34  a,  b    show    evident  NH  (i)  →  NH  (i+1) 
connectivities  (red  lines),  indicative  of  an  highly  folded  conformation  of  the 
peptide
104,105.  
                 Besides, to test the participation of the amide protons in intramolecular 
hydrogen  bonds,  the  evolution  of  the 
1H  NMR  spectra  of  fullerene-peptides-
references  2+  and  2-  were  studied  as  a  function  of  the  good  H-bond  acceptor 
Me2SO-d6 
60.  
                Figure  3.35  clearly  shows  two  classes  of  NH  protons  for  the  fullerene-
peptide-reference  2-:    the  first  class,  N(1)H  and  N(2)H,  includes  protons  whose  
chemical shifts  are  remarkably sensitive to the addition of  the H-bonding acceptor 
solvent Me2SO-d6;  the second class N(3)H and N(4)H includes those  displaying  a  
behavior    characteristic    of    shielded  protons  (very  modest  sensitivity  of  the 
chemical shifts to the solvent composition). The absence of effects brought about 
on the N(3)H and N(4)H protons points to the failure of Me2SO-d6 to disrupt the 
intramolecular H-bonds involving them.  
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Figure  3.28.  Molecular  structure  of  the  fullerene-peptide-reference  2-  where  the 
intramolecular hydrogen bonds are evidenced.  
 
Since in the 310 –helix, the formation of stable intramolecular H-bonds starts from 
the N(3)H proton, it can thus be inferred that the fullerene-peptide-reference 2- 
adopts such an ordered secondary structure.  
                   As  far  as  the  fullerene-peptide-reference  2+  is  concerned,  figure  3.36 
again shows two class of protons: not shielded N(2)H (its chemical shift is sensitive 
to the Me2SO-d6  addition) and two shielded amide protons N(3)H and N(4)H.  
 
 
Figure 3.29. Molecular structure of the fullerene-peptide-reference 2+ where the 
intramolecular hydrogen bonds are evidenced.  
 
From figure 3.36, it is clear how the N(1)H shows an anomalous behavior. Not only 
its chemical shift is not consistent for a free NH group but also its chemical shift only 
slightly increases with Me2SO-d6   addition. This  trend  is not in  line  with  the  
normal  behavior  of  Aib  homopeptides  for  which  the  sensitivity  of  the  N(1)H  
protons  is  notably  higher  than  that  of  the  N(2)H protons. The insensitivity of 
the N(1)H chemical shift to the addition of Me2SO-d6  suggests how this proton can 
be engaged in some sort of interaction. This observation is consistent with the FT-IR 
spectrum of fullerene-peptide-reference 2+ (Figure 3.27). The band of the free NH 
in the amide A region results less intense compared with the corresponding band in 
the peptide-reference 2+ FT-IR spectrum. The peptide-reference 2+ only lacks of the 
C60 moiety and retains the same number of NH groups; therefore, the decrease in 
intensity of the free NH band can be accounted for a lower number of free NH 
groups in comparison with the number of free NH groups present in the peptide-
reference 2+. 
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Figure 3.30. 200 MHz 
1H NMR spectrum of fullerene-peptide-reference 2-  in CDCl3 , 
20°C, 2 mM. 
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Figure 3.31. 200 MHz  
1H NMR of fullerene-peptide- reference 2+ in CD2Cl2, 20°C, 2 
mM.   67 
Figure 3.33 a. Full 2D ROESY spectrum in CDCl3 of 3 mM fullerene-peptide-reference 
2-.  
 
Figure 3.33 b. 2D ROESY spectrum in CDCl3 of 3 mM fullerene-peptide-reference 2- in 
the NH protons resonance region. NH (i) → NH (i+1) connectivities are shown (red 
lines).   68 
 
Figure 3.34 a. Full 2D ROESY spectrum in CDCl3 of 3 mM fullerene-peptide-reference 
2+.  
 
 
Figure 3.34 b. 2D ROESY spectrum in CDCl3 of 3 mM fullerene-peptide-reference 2+ 
in the NH protons resonance region. NH (i) → NH (i+1) connectivities are shown (red 
lines).   69 
 
Figure 3.35. 
1H NMR titration in CDCl3 :  Variation of the chemical shifts of the four 
amide protons of 1 mM fullerene-peptide-reference 2- as a function of the addition 
of Me2SO-d6. 
 
Figure 3.36. 
1H NMR titration in CDCl3 :  Variation of the chemical shifts of the four 
amide protons of 1 mM fullerene-peptide-reference 2+ as a function of the addition 
of Me2SO-d6. 
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3.3.3 Quenching of the systems bearing the nitroxide 
monitored by cw EPR 
 
                    The presence of the free radical in the 2+ and 2- systems bearing the 
nitroxide was proved by cw EPR spectra which show the typical three lines pattern 
of the nitroxide due to the 
14N (I = 1) nuclei hyperfine coupling with a g value of 
2.0061  and  aN  ~  15.3  G 
14,30-34  (Figures  3.39  a,  b).  The  measurement  of  g  was 
performed by measuring B at the zero of the first derivative signal of the central line 
of the EPR spectrum. It is worth stressing that here we wanted only a qualitative 
measurement  of  g  and  aN  since  many  factors  concur  to  determine  these  two 
parameters such as temperature, signal distortions, frequency counter accuracy, 
stability of the frequency and of the magnetic field and other instrumental factors, 
limits on the accuracy of the natural constants (h, βe)
49; therefore, a standard is 
required when a precise determination is sought. In EPR spectra of 2+ and 2- series, 
further splitting by the protons of the methyl substituents and by the methilene 
protons of the piperidinic ring are not resolved
30. Without entering into details, the 
three EPR  lines show different widths because of the uncomplete averaging of 
anisotropic  hyperfine  interactions  and  the  g  tensor.
49  Spectra  were  acquired  in 
CHCl3, 0.05 mM concentration so that interactions between paramagnetic centers 
should  be  negligible;  this  was  done  to  avoid  line  broadening  by  spin-spin 
interaction. Microwave losses and sample heating due to non-resonant absorption 
of  the  electric  component  by  the  electric  dipoles  of  solvent  was  reduced  by 
employing capillaries 2x3 mm o.d. Diphenylhydrazine (PH)
100 was used to quench 
(here quench is meant as the change of the redox state of the native radical) the 
free radical according to the following reaction scheme:   
 
Figure 3.37. Reaction scheme for the reduction of the nitroxide. 
 
                 Various alternative mechanisms for the reduction of nitroxides by PH were 
been proposed
101. In the mechanism depicted in figure 3.38, the nitroxide  forms  an  
H-complex  with  PH,  in which  the  oxygen atom  of the nitroxide  donates  a  lone 
pair to a hydrogen atom  of the  PH  NH-group. According  to   this   scheme,   
formation  of  the   final product,   hydroxylamine,  requires  transfer  of  an electron  
from  the  lone  pair  of the  PH  nitrogen  atom  to the  nitrogen  atom  of the  
nitroxyl  group  with  concerted or subsequent  proton transfer from the  NH-group 
to the  nitroxide  oxygen  atom. 
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Figure 3.38. Possible reaction mechanism for the reduction of the nitroxide through 
PH. 
                The most likely alternative appears to be the following: an NH group of PH 
attaches to a π-orbital of nitroxide through the σ-bond of a hydrogen atom, forming 
a  π-σ  type  complex.  In  this  case  there  are  fewer  steric  hindrances  than  in  the 
previous case. The π-complex lies on the reaction coordinates of hydrogen atom 
transfer. However, when passing through the reaction coordinates, the system can 
jump over the complex state. 
                   PH  solutions  in  CDCl3  were  freshly  prepared  prior    to  each   series  of  
experiments,  and  used within  a 30 minutes. Quenching was monitored by cw-EPR. 
Digital double integration of the EPR signal was performed: two integrations ( a 
“running” one to obtain the signal in absorption and a “numerical” one to yield 
simply a number) were needed to obtain the desired area from the experimentally 
obtained  first-derivative  profile.  The  area  is  of  particular  interest  since  it  is 
proportional  to  the  number  of  nitroxide  in  the  sample
49.  Therefore,  the  ratio 
between  the  area  of  the  EPR  signal  before  and  after  addition  of  the  quencher 
provides a measure of the amount of quenched nitroxide in the sample. Several EPR 
spectra were recorded at different times, after addition of the quencher to the 
solution containing the sample (Figures 3.39 a, b). The plot of figure 3.40 show the 
percent of quenched nitroxide over time. It is important to stress that we did not 
want a precise quantification of the nitroxide concentration in solution but only a 
qualitative idea of how fast the nitroxide was reduced. In fact, the area of the EPR 
signal is affected not only by the number of nitroxide moieties in the sample but 
also  by  other factors  such  as temperature,  applied  magnetic field  magnitude  B, 
microwave frequency, the amplitude B1 of the microwave magnetic field effective 
at the sample, the overall spectrometer gain
49 and, as already stressed, the use of a 
standard would be required  for quantitative determination. 
                   The reduction reaction was observed to be reversible. Indeed, when the 
integral of EPR signal reached the minimum value, corresponding to the plateau in 
the graph “% nitroxide quenched“ against “time” (Figure 3.40), the integral does not 
decrease anymore, on the contrary, a slight increase is observed. In fact, it is known 
that the N-hydroxy-amine is oxygen sensitive
72. 
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Figure 3.39 a. cw EPR spectrum of fullerene-peptide 2-  in a 0.05 mM CHCl3 solution 
monitored  over  time  after  have  added  10  equivalents  of  PH  at  r.t,  microwave 
attenuation 10 dB. 
Figure 3.39 b. cw EPR spectrum of fullerene-peptide 2+ in a 0.05 mM CHCl3 solution 
monitored over time after having  added 10 equivalents of PH at r.t., microwave 
attenuation 10 dB.   73 
                     The reduction kinetic is here shown: 
Figure 3.40. Reduction kinetic for the 2- and 2+ series under the same conditions; 
0.05 mM CHCl3 solution with 10 equivalents of PH, r.t. 
 
 
  k (min
-1) 
 
k2- / k2+ 
Fullerene-peptide 2-  0.043  4.5 
Fullerene-peptide 2+  0.0095   
Peptide-reference 2-  0.033  4.5 
Peptide-reference 2+  0.0074   
 
          The graph in figure 3.40 shows that, under the same conditions, the fullerene-
peptide 2+ is reduced four times slower than the fullerene-peptide 2- where the 
sign of dipole moment is reversed and the plus sign of the dipole is on the TOAC. 
Same behavior is observed in the two peptides-reference which only lack of the C60 
moiety and retain the same number of NH groups. The origin of this rate difference 
can be ascribed to the opposite direction of the macrodipole moment associated 
with  the  peptide helical  structure.  In  the  plus  series,  negative  charge density  is 
located on TOAC. In principle, this charge could yield the reduction process more 
difficult, acting like an electro-donating group attached on TOAC. In the minus series 
the situation is reversed and here the positive charge of the macrodipole is on TOAC 
thus affecting favorably the reduction process, acting like an electro-withdrawing 
group attached on TOAC. 
                  It is also worth noting that the systems bearing the fullerene are reduced 
faster by a factor of 1.3 compared with their peptides-reference. It is known that 
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the buckyball behaves such as a fairly localized and electron-deficient polyolefin
1,6a 
and tends to form complexes with electron donors
12. The possible formation of a 
transient complex between PH and the π-system of the fullerene could explain the 
catalytic effect observed on the reaction. 
 
3.3.4 
1H NMR characterization of systems bearing the 
nitroxide 
 
                TOAC  derivatives  can  not  be  characterized  by 
1H  NMR  because  the 
paramagnetic  center  relaxes  very  rapidly,  thereby  causing  strong  broadening  of 
NMR lines of nuclei in its vicinity. Even at longer distances than 6Å NMR lines may 
still  be  broadened  beyond  detectability
49.  Well  resolved  NMR  spectra  can  be 
acquired after quenching of the free radical. To this purpose, PH was used. Spectra 
were acquired in CDCl3 at r.t. before and after quenching, to show the appearance 
of peaks. A comparison with the corresponding references was also done. In the 
spectra  of  the  quenched  systems  (Figures  3.42,  3.43,  3.44,  3.45),  the  following 
peaks located at 5.58, 6.85, 7.21, 7.53, 7.93 ppm belong to the oxidated PH and to 
PH present in excess. Besides PH is known to produce by-products
111.    
 
 
Figure 3.41. 
1H NMR of 2 mM PH in CDCl3, r.t. 
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                   For  the  2+  system  50  equivalents  of  PH  were  used  instead  of  10, 
according to the kinetic study (Figure 3.40) which showed a slower quenching for 
the 2+ system compared with the 2- system.  
                      Before  quenching,  the 
1H  NMR  spectra  of  the  systems  bearing  the 
nitroxide show a bunch of broad and unresolved peaks in the aliphatic region. No 
other signal is observable. After quenching, peaks related to the expected products 
appear resolved and in good agreement with the corresponding fullerene-peptides-
reference peaks (Figures 3.42, 3.43, 3.44, 3.45).  
                      The  peaks  corresponding  to  the  methylene  groups  of  the  TOAC 
piperidinyl ring appear at 2.4 ppm for the fullerene-peptide 2+ (Figure 3.43) and at 
2.3  ppm  for  the  fullerene-peptide  2-  (Figure  3.42)  in  good  agreement  with  the 
corresponding peaks of the peptides-reference 2+ and 2- (Figures 3.44 and 3.45). 
The resonances of the four TOAC methyl groups fall at higher fields, i.e., at 1.24ppm 
for the fullerene-peptide 2+ and at 1.35 ppm for the fullerene-peptide 2- (Figures 
3.42 and 3.43). 
                       It is possible to observe that, in the 
1H NMR spectrum of the peptide-
reference 2+ (Figure 3.45), the N(1)H amide proton peak is shifted to high fields and 
no singlet is observable at 8.2 ppm, similarly to the 
1H NMR spectra of fullerene-
peptide  2+  and  fullerene-peptide-reference  2+  (Figure  3.43).  Finally,  the 
fulleropyrrolidine and alanine peaks (
αH and 
αCH3) are not visible in the 
1H NMR 
spectrum of peptide-reference 2+ and 2- (Figures 3.44 and 3.45). 
   
1H NMR titration was not possible for the systems 2+ and 2- bearing 
the nitroxide because the presence of the quencher signals in the aromatic region 
of the NMR spectrum covers the amide protons peaks of the systems 2+ and 2- so 
that it is not possible to follow their shifts. It is known, however, that TOAC and Aib 
share  the  same  structural  tendencies  when  in  peptides  and  thus  a  reasonable  
assumption is that the fullerene-peptides should retain the same conformations of 
their corresponding fullerene-peptides-reference. As previously suggested by FT-IR 
analysis (Figures 3.27 a, b) whereas this assumption appears as valid for the 2+ 
series, for the 2- series the  substitution of the TOAC residue with the Aib residue 
appears  to affect significantly the interactions involving the NH groups.  
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Figure 3.42 a. 500 MHz 
1H NMR of fullerene-peptide 2- before and after quenching 
with 10 equivalents of PH, fullerene-peptide-reference 2-, in CDCl3, r.t., 2 mM. 
Figure 3.42 b. Partial 500 MHz 
1H NMR of fullerene-peptide 2- before and after 
quenching,  fullerene-peptide-reference  2-,  in  CDCl3,  r.t.,  2  mM.  NH  resonances 
region.   77 
 
Figure 3.43 a. 500 MHz 
1H NMR of fullerene-peptide 2+ before and after quenching 
with 50 equivalents of PH, fullerene-peptide-reference 2+, in CDCl3, r.t., 2 mM. 
Figure 3.43 b. Partial 500 MHz 
1H NMR of fullerene-peptide 2+ before and after 
quenching,  fullerene-peptide-reference  2+,  in  CDCl3,  r.t.,  2  mM.  NH  resonances 
region.   78 
 
Figure 3.44 a. 500 MHz  
1H NMR spectrum of peptide-reference 2-  before and after 
quenching with 10 equivalents of PH, fullerene-peptide 2- after quenching with 10 
equivalents of PH, in CDCl3, r.t., 2 mM. 
Figure  3.44 b. Partial 500 MHz  
1H NMR spectrum of peptide-reference 2- before 
and after quenching with 10 equivalents of PH, fullerene-peptide 2- after quenching 
with 10 equivalents of PH, in CDCl3, r.t., 2 mM. NH resonances region.   79 
 
Figure  3.45 a. 500 MHz  
1H NMR spectrum of peptide-reference 2+  before and after 
quenching with 50 equivalents of PH, fullerene-peptide 2+ after quenching with 50 
equivalents of PH, in CDCl3, r.t., 2 mM. 
 
Figure  3.45 b. Partial 500 MHz  
1H NMR spectrum of peptide-reference 2+ before 
and after quenching with 50 equivalents of PH, fullerene-peptide 2+ after quenching 
with 50 equivalents of PH, in CDCl3, r.t., 2 mM. NH resonances region.   80 
3.3.5 Uv-vis characterization of fullerene-peptides 
 
                  The fullerene-peptides show superimposable UV-vis absorption spectra 
(Figure 3.46) with very similar ε values The spectra show a strong absorption at 310 
nm and a sharp peak at 430 nm, latter being typical of monomeric fulleropyrrolidine 
derivatives 
18a,41,102,108. The former corresponds to the C60 electronic transition with 
high oscillator strength from the ground state to the 3
1T1u, already observed at 
328.4  nm  in  n-hexane  solutions 
18a.  It  is  noteworthy  to  stress  that  chloroform 
prevents  the  observation  of  the  bands  at  about  254  nm,  also  peculiar  for 
fulleropyrrolidine derivatives
103. 
 
Figure 3.46. UV-vis spectra of 0.01 mM fullerene-peptides in CHCl3 at r.t . 
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  3.3.6 Electrochemical investigation of systems 2+ and 2- 
 
                The  electrochemical  investigation of  compounds  of  interest was  carried 
out  in  1,2-dichloroethane  (DCE)  at  25°C  with  TBAH  (tetrabutylammonium 
hexafluorophosphate) 0.1 M as supporting electrolyte and using ferrocene (Fc) as 
internal redox standard. In order to perform the measurements with a less volatile 
solvent, DCE (b.p. 84°C) was employed to dissolve the fullerene-peptides instead of 
CHCl3 (b.p. 61°C). Both cyclic voltammetry (CV) and differential pulse voltammetry 
(DPV)  were  carried  out.  Due  to  the  limited  amount  of  products  available,  the 
measurements were carried out in a microcell that allowed to work with a limited 
volume of electrolytic solution, usually 1 mL. Glassy carbon was used as the working 
electrode material.  
                 The voltammetric behavior of the two fullerene-peptides-reference 2+ and 
2-, that bear as the only redox active group the fullerene moiety, is characterized by 
the  presence  of  four  reduction  peaks  in  the  potential  window  available  in  DCE 
(Figure 3.47).  
Figure  3.47.  Background-subtracted  CV  curves  of  0.81  mM  fullerene-peptide-
reference 2+  in 0.1 M TBAH / DCE at a scan rate of 0.1 V/s. 
 
Such peaks corresponds to successive electron injection events into the fullerene. 
All  the  peaks  are  reversible  apart  for  the  most  negative  one,  relative  to  the 
formation  of  C60  tetra-anion,  that  shows  a  typical  catalytic  behavior,  that  is, 
irreversibility and an increase of the cathodic current with respect to the other 
peaks. This is most probably due to the reduction of the solvent by the C60
 tetra-
anion. In the following, we will then consider only the first three reduction peaks. 
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From the background subtracted CV of fullerene-peptides-reference 2-, shown in 
figure  3.48,  it  is  possible  to  appreciate  the  chemical  and  electrochemical 
reversibility of the three electron transfer reactions.  
Figure  3.48.  Background-subtracted  CV  curves  of  0.77  mM  fullerene-peptide-
reference 2-  in 0.1 M TBAH / DCE at a scan rate of 0.1 V/s. 
 
Figure 3.49. Background-subtracted CV curves of 1 mM fullerene-peptide-reference 
2- (dashed line) and fullerene-peptide-reference 2+ (continue line)  in 0.1 M TBAH / 
DCE at a scan rate of  0.1 V/s.  
   83 
The separation between the cathodic and the anodic peak, once a good feedback 
correction of the ohmic drop was carried out, are in all cases about 60 mV. By 
comparing the E° values of the two species (Chart 3.57), calculated as the average 
of  cathodic  and  anodic  peak  potential,  it  is  possible  to  observe  that  the  first 
reduction  of  fullerene-peptide-reference  2-  is  shifted  negatively  (14  mV)  with 
respect to fullerene-peptide-reference 2+ (Figure 3.49). Apart from the difference in 
the direction of the macrodipole, the only other distinction between the 2+ series 
and the 2- series is on the bond that links the fullerene to the peptide. In the 
fullerene-peptide 2- (with or without TOAC), the peptide is attached to the C60 via 
amide bond (Figure 3.50) while in the fullerene-peptide 2+ (with or without TOAC), 
a  tertiary  amino  group  links  the  peptide  to  the  fullerene  (Figure  3.51).  As  a 
consequence,  one  could  expect  that  the  reduction  of  the  C60  in  the  fullerene-
peptide 2- was anticipated in respect to the fullerene-peptide 2+ being the carbonyl 
group  of  the  amido  bond  an  electro-withdrawing  group.  Indeed  this  shift  was 
already  observed  by  comparing  the  first  reduction  potential  of  N-acyl-
fulleropyrrolidine with N-methyl-fulleropyrrolidine. The E° were found to be -1.00 V 
and -1.05 V respectively
24. What we observe experimentally instead, goes in the 
opposite direction, namely, the first reduction of fullerene-peptide 2+ is anticipated 
in respect to the first reduction of fullerene-peptide 2- and this potential shift is 
consistent with the expected effect brought about by the peptide macrodipole. In 
fact in the 2- series, the minus sign of the peptide macrodipole is on the fullerene 
(Figure 3.50).  
Figure  3.50  .  Molecular  structure  of  fullerene-peptide-reference  2-.  The  peptide 
macrodipole is represented. In the fullerene-peptide-reference 2-  the TOAC residue 
(in red) is an Aib residue. 
 
In the 2+ series we have the plus sign located on the C60 moiety instead (Figure 
3.51).  
Figure  3.51  . Molecular  structure  of  fullerene-peptide-reference  2+-.  The  peptide 
macrodipole is represented. In the fullerene-peptide-reference 2+  the TOAC residue 
(in red) is an Aib residue. 
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In the 2- series, the negative charge density on fullerene, produced by the peptide 
macrodipole, can produce an effect similar to the one introduced by an electro-
donating  substitutent  covalently  attached  on  fullerene  which  tends  to  raise  the 
LUMO’s energy
121 (lowest unoccupied molecular orbital) of the fullerene moiety. An 
increase of the LUMO energy makes the reduction more difficult because addition 
of an electron to the fullerene’s LUMO requires more energy and thus shifts the 
cathodic potential to more negative values.  In the 2+ series, the effect is reversed, 
being the positive charge density brought by the macrodipole on C60. Here, the 
macrodipole behaves like an electro-withdrawing substituent which tends to give 
rising to a decrease in LUMO energy
121 and thus causes the reduction to occur at 
less  negative  potentials.  This  effect  was  already  observed  for  C60  derivatives 
functionalized  with  electro-withdrawing  groups  such  as  cyanos
23  or  carbonyls
24 
groups.  In  these  derivatives  the  first  reduction  peak  of  C60  is  anticipated  with 
respect to the pristine fullerene. Regarding the E° of second and third reduction 
peaks,  no  shift  is  observed  between  the  fullerene-peptide-reference  2+  and  2- 
(Figure 3.49) suggesting that the dipole moment effect fades away in the second 
and third reduction. 
                  The voltammetric analysis of fullerene-peptides 2+ and 2- allowed us to 
verify that the reduction potentials in both series are coincident (Figure 3.52). 
 
Figure 3.52. Background-subtracted CV curves of fullerene-peptide-reference 2+ and 
fullerene-peptide 2+  in 0.1 M TBAH / DCE at a scan rate of 0.1 V/s. 
  
In the CVs of both fullerene-peptides 2+ and 2- CVs the only relevant difference 
with the CVs of their corresponding fullerene-peptides-reference is the presence of 
a shoulder before the third reversible reduction peak of C60. This is attributed to the   85 
reduction of the nitroxide radical function (Figure 3.52). The reduction of N-O• is 
known to be irreversible and to give rise to a peak that reflects the occurrence of a 
rather complex reaction. 
 
Figure  3.53.  DPVs  of  fullerene-peptide  2-  (dashed  line)  and  fullerene-peptide  2+ 
(continue line)  in 0.1 M TBAH / DCE. 
 
                       On  the  oxidation  side,  by  scanning  the  potential  positively  a  single 
reversible  peak  is  observed.  This  is  due  to  the  oxidation  of  the  TOAC  nitroxide 
radical  to  the  oxoammonium 
cation (Figure 3.53). This oxidation 
process is electrochemically quasi-
reversible,  as  the  CVs  are  
characterized by a peak separation 
of about 70 mV (Figure 3.54). The 
difference  on the  position  of  this 
peak  when  one  goes  from  the 
fullerene-peptides  2+  to  the 
corresponding system 2- is clearly 
evident.  
 
Figure 3.54. Background-subtracted CV curves of fullerene-peptide 2- (dashed line) 
and fullerene-peptide 2+ (continue line)  in 0.1 M TBAH / DCE at a scan rate of  0.1 
V/s. The potential window was restricted to where the nitroxide oxidation takes 
place. 
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Nitroxide  oxidation  in  fullerene-peptide  2+  is  considerably  easier  than  that  of 
fullerene-peptide  2-  by  80  mV,  and  once  again,  this  shift  is  on  the  direction 
expected for a dipole moment effect. Indeed in the 2+ series, the negative part of 
the dipole is on the TOAC side. Again, the dipole effect can be compared to the one 
brought about by an electro-donating group which tends to raise the energy of the 
SOMO
121  (singularly  occupied  molecular  orbital).  High-energy  SOMOs  are  more 
willing to give up an electron than to accept an electron
121 , thus favouring the 
oxidation. In the 2- series, the positive side of the dipole is on TOAC. Again, the 
dipole effect can be compared to the one brought about by an electro-withdrawing 
group which tends to decrease the energy of the SOMO
121. Low-energy SOMOs are 
more willing to accept an electron than to give up an electron
121 thus shifting the 
oxidation to more positive values.  
                     To verify that the potential shifts are independent by the presence of 
the  fullerene  moiety  and  due  only  to  the  peptide  macrodipole  orientation, 
peptides-reference 2+ and 2- were studied. These two compounds only lacks of the 
C60 moiety but retains the same number of NH groups. The oxidation potentials of 
the TOAC nitroxide in the two compounds (Chart 3.57) differs by as much as 90 mV 
and are, respectively, 8 and 17 mV more positive respect to fullerene-peptides 2+ 
and 2-. This result confirms the relevant effect of the helix dipole moment on the 
energy of the TOAC’s SOMO.   
                      It is worth mentioning that addition of ferrocene, our internal redox 
standard for the potential values, does not induce any shift in the peak positions 
(Figure  3.55)  allowing  us  to  state  that  ferrocene  is  not  interacting  with  the 
substrate. 
 
Figure 3.55. DPVs of fullerene-peptide 2+ (red line) and fullerene-peptide 2+ (black 
line) in the presence of Fc, in in 0.1 M TBAH / DCE.    87 
                   At this point it is interesting to compare the oxidation potential of a TOAC 
derivative (Boc-TOAC-NHtBu) with the potentials obtained for our systems bearing 
the nitroxide.  Boc-TOAC-NHtBu  (Figure  3.56)  is protected  at  the  amino  function 
with a urethane (Boc) and the carboxylic function of the aminoacid is transformed 
into a secondary amide (tert-butyl amide). This derivative is not a peptide and thus 
it can not posses an oriented dipole moment such as the one that characterizes our 
systems.  
 
Figure 3.56 Molecular structure of Boc-TOAC-NHtBu. 
 
In  the  absence  of  any  oriented  dipole  moment,  the  oxidation  potential  of  Boc-
TOAC-NHtBu falls at 0.262 V, thus lying roughly in the middle of the values found for 
the  nitroxide  oxidation  in  the  plus  and  minus  series  (Chart  3.57).  This  outcome 
points  out  the  important  role  played  by  helix  dipole  on  the  variation  of  the 
potentials which reflect a different modulation, induced by the charge distribution 
of the helix dipole, on the energy of fullerene’s LUMO and TOAC’s SOMO. 
 
             
 
Reduction  Fulleropyrrolidine    Oxidation 
Nitroxide 
  E°1 (V) vs Fc 
 
E°2 (V) vs Fc  E°3 (V) vs Fc  E° (V) vs Fc 
Fullerene-peptide 2+  -1.056  -1.458  -1.973  +0.202 
Fullerene-peptide-reference 2+   -1.056  -1.458  -1.972   
Peptide-reference 2+        +0.210 
Fullerene-peptide 2-  -1.073  -1.460  -1.974  +0.283 
Fullerene-peptide-reference 2-   -1.070  -1.457  -1.972   
Peptide-reference 2-        +0.300 
Boc-TOAC-NHtBu        +0.262 
 
Chart 3.57. Standard potentials of  investigated systems. 
 
 
 
 
Nitroxide standard potentials (V)
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4. Conclusion 
                   
                     This  Thesis  concerns  the  synthesis, characterization and investigation 
of a series of compounds in which fullerenes, peptides, and radicals are coupled. In 
particular, two series of compounds were synthesized which are characterized by 
the presence of a fullerene moiety and / or of a nitroxide function covalently linked 
at  the  extremity  of  a  rigid  peptide.  The  peptide,  mainly  built  of  Aib  residues, 
presents two intramolecular hydrogen bonds and tends to assume very likely a 310-
helix secondary structure. The structured peptide sustains a strong oriented dipole 
moment located along the main axes of the molecule. The direction of the dipole is 
opposite  in  the  two  series,  named  2+  and  2-,  and  this  was  expected  to  cause 
opposite effects, for example, on the redox properties of the moieties located at its 
extremity.  
                    The syntheses required a considerable amount of experimental work, 
also because of the extremely low yields of some of the steps, which forced us to 
abandon some strategies that, in principle, could have been possible. In this Thesis 
are also described for the first time some new nitroxide and fullerene derivatives 
(only  similar  examples  were  described  in  literature).  The  method  chosen  to 
functionalize the fullerene was the Maggini-Prato reaction because it allowed us to 
work with readily accessible materials and to obtain the fullerene-peptides 2+ and 
2-  only  by  modifying  the  substituent  at  the  nitrogen  atom  of  the  dipolarophile 
precursor. The method also does not require strong conditions and any particular 
functional groups to stabilize the intermediate responsible for the cycloaddition, 
which  could  interfere  with  the  electrochemical  analysis.  Eventually,  we  could 
synthesize  the  following  compounds:  the  fullerene-peptides  2+  and  2-,  the 
fullerene-peptides-reference 2+ and 2- and the peptides-reference 2+ and 2-.     
                    Characterization  in  solution  (Mass  Spectrometry,  FT-IR  absorption 
spectroscopy, 
1H  NMR  spectroscopy)  proves  the  identity  of  compounds  under 
investigation. It also provides evidence of the presence of structured peptides in 
both series 2- and 2+. FT-IR absorption spectra of systems 2+ and 2- reveal the 
presence of bonded amide protons (involved in intramolecular hydrogen bonds) 
and free amide protons. 
1H NMR and 
13C NMR spectra are fully compatible with the 
structures  of  the  fullerene-peptide-references  2+  and  2-.    2D  ROESY  spectra 
provided  evidence  of  highly  folded  conformation  of  both  fullerene-peptide-
references. 
1H  NMR  titrations  revealed  two  different  classes  of  NH  protons: 
shielded  (involved  in  intramolecular  hydrogen  bonds)  and  not  shielded  (free 
solvated  NH  protons). 
1H  NMR  spectra  of  fullerene-peptides  2+  and  2-,  after 
quenching with diphenylhydrazine are in good agreement with the spectra of the 
corresponding fullerene-peptides-reference. Peaks related to the TOAC moiety are 
also  visible.  UV-vis  absorptions  of  fullerene-peptides  are  typical  of  monomeric 
fulleropyrrolidine derivatives. Nitroxide quenching with diphenylhydrazine is four 
times slower for the 2+ system compared with the 2- system, which suggests that 
the rate difference is not due to the presence of the fullerene but, most likely, to 
the difference of the direction of the macrodipole.  
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                       Cyclic  voltammetries  clearly  show  that  the  first  reduction  peak  of 
fullerene  is  anticipated  in  the  2+  series  with  respect  to  the  2-  series.  This 
experimental outcome is in full agreement with the effect caused by the peptide 
macrodipole. An even more accentuated deviation is found on the oxidation side 
(TOAC  oxidation)  where  the  potential  shifts  are  once  again  on  the  direction 
expected for an effect of the helix dipole moment, namely, easier reduction and 
easier oxidation for the 2+ series while more difficult reduction and more difficult 
oxidation for the 2- series. It is thus possible to state that the helix dipole moment 
plays an important role on the tuning of the potentials of the active redox groups. 
                     It is worthwhile to note that Aib homopeptides posses an high tendency 
to  give  raise  to  structured  peptides  which  is  already  evident  from  very  short 
oligomers
62,64,65. The unique rigidity of short Aib homopeptides, provided by the 
peculiar backbone stiffness, qualify them as a successfully spacers in spectroscopic 
investigations. Thank to this unique feature, it can be assumed that the nitroxide-
C60 distance in the fullerene-peptides, obtained from molecular modeling, is a good 
approximation to the true value. An accurate estimation of the distance is crucial 
for  several  investigations  where  the  interactions  between  the  fullerene  (or  the 
hydrogen molecule encapsulated inside its cage) and the nitroxide are distance-
dependent. The fullerene-peptide 2+ and 2- were thus studied by TR EPR (Time-
Resolved  Electron  Paramagnetic  Resonance)  by  Dr.  Marco  Ruzzi.  The  technique 
allowed us to investigate the coupling, that is distance-dependent, between the 
doublet  ground  state  of  the  nitroxide  and  the  triplet  state  of  the  fullerene 
generated after photo-excitation. Furthermore, the H2@fullerene-peptide 2+ and 2- 
were analyzed by 
1H NMR spectroscopy by Dr. Yongjun Li in the Turro Group and 
the  nuclear  spin  relaxations  and  the  ortho  /  para  conversion  rates  of  the 
encapsulated  hydrogen  were  obtained.  The  research  regarding  the  ortho  /para 
hydrogen and the H2@C60 has been studying in the Turro Group since many years by 
now and papers about this topic can be found in the references. The Turro group, 
by varying the spacers of a series of H2@fullerene-nitroxide derivatives, obtained a 
clear distance-dependence of the nuclear spin relaxation and of the ortho / para 
conversion rate of the encapsulated hydrogen. The values obtained by studying the 
H2@fullerene-peptides  could  provide  a  further  evidence  of  this  distance-
dependence thank to the accuracy with which the distance is estimated. 
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